Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.7571656165186142,-1.935830695264218,0.0,0.14059445091276554,0.111,5/12,3.56%,IGF1;INSR;GNAS;PIK3R1;IGF2
prerank,G protein-coupled receptor binding (GO:0001664),0.5910246932198677,1.9252729585206956,0.0,0.3169067426277798,0.253,11/132,4.96%,PTCH1;GNA14;ITGB4;PTCH2;HOMER2;WNT10A;WNT2B;WNT16;GNAQ;UTS2B;WNT5A
prerank,sterol binding (GO:0032934),0.651440147113305,1.9003709033909881,0.001310615989515072,0.24791052989350337,0.363,5/56,0.67%,PTCH1;RORA;APOD;CAV1;VDAC2
prerank,cholesterol binding (GO:0015485),0.641092242933862,1.8219867155244742,0.004032258064516129,0.5145372738160748,0.721,4/47,0.67%,PTCH1;APOD;CAV1;VDAC2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6932235414569814,-1.7994355096606476,0.004608294930875576,0.42013576151666265,0.498,4/13,1.14%,PDGFD;IL1R1;PDGFRB;PDGFRA
prerank,death receptor binding (GO:0005123),0.7932417940899381,1.7956561573151546,0.008223684210526315,0.5300812481791991,0.81,2/15,0.24%,NGF;EDA
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6519042962467214,1.7864523088460293,0.008708272859216255,0.47221959667238533,0.836,10/35,8.36%,PKDCC;TEC;ITK;CLK1;TXK;PEAK1;SRC;FER;ABL2;DYRK1A
prerank,gap junction channel activity (GO:0005243),-0.5899260728093237,-1.7663020982633735,0.0,0.39505576180956775,0.613,4/22,2.70%,GJB6;GJC1;GJD3;GJA1
prerank,wide pore channel activity (GO:0022829),-0.5823439926012377,-1.754589397657546,0.0,0.3295182443267942,0.644,4/23,2.70%,GJB6;GJC1;GJD3;GJA1
prerank,receptor antagonist activity (GO:0048019),0.7348698571774701,1.7435955979681288,0.01001669449081803,0.6152558832097887,0.935,2/17,0.99%,PXDN;DKKL1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7155376883576428,-1.7385722446970029,0.007246376811594203,0.3086487555194306,0.702,4/11,15.14%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7085610505767959,-1.7279994455630585,0.0049382716049382715,0.28777926671206694,0.744,5/10,13.44%,SHANK3;GNAS;SQSTM1;IGSF11;SHANK2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7339447518597904,-1.717634109291385,0.006896551724137931,0.27271557554284204,0.778,4/10,8.23%,SLCO3A1;SLCO1C1;SLC22A6;SLCO2A1
prerank,insulin-like growth factor I binding (GO:0031994),0.7458647630601722,1.6869663263356498,0.013136288998357963,0.916460039491147,0.99,3/13,0.32%,ITGB4;ITGA6;IGFBP6
prerank,insulin-like growth factor binding (GO:0005520),0.7248708237368184,1.679947750918344,0.008264462809917356,0.8536496941054608,0.993,3/15,0.32%,ITGB4;ITGA6;IGFBP6
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.5144836133183612,-1.6437161312006925,0.012121212121212121,0.4732705784143582,0.94,10/27,9.89%,SLC22A8;SLC26A7;ANO1;SLC39A8;SLC22A6;SLC26A2;SLC39A14;SLC25A30;SLC25A11;LRRC8A
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7250590285529994,1.6097694935355242,0.033444816053511704,1.0,1.0,2/14,2.53%,RDH10;RDH5
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5715916470458818,-1.59494708705707,0.018276762402088774,0.62156904383569,0.983,6/18,2.84%,ENG;SMAD3;SMAD6;TGFBR3;FKBP1A;TGFBR1
prerank,neuropeptide receptor activity (GO:0008188),0.621533355720729,1.5933049591856283,0.04329004329004329,1.0,1.0,3/29,2.77%,SORCS2;SSTR1;KISS1R
prerank,lipoprotein particle receptor binding (GO:0070325),-0.49283072510138065,-1.5918247530079555,0.020958083832335328,0.5729223874695196,0.983,8/27,13.61%,PICALM;LRP1;AP2A1;APOE;DNAJA1;LDLRAP1;ANKRA2;MESD
prerank,O-acyltransferase activity (GO:0008374),0.59489777354412,1.5784756776143423,0.044977511244377814,1.0,1.0,6/30,7.22%,MBOAT2;MOGAT2;MOGAT3;GPAT3;AWAT2;SOAT1
prerank,actinin binding (GO:0042805),0.6301779358319274,1.570407029472758,0.05509181969949917,1.0,1.0,6/21,7.46%,MAGI1;KCNA5;PDLIM4;CSRP3;DAG1;RARA
prerank,CoA-ligase activity (GO:0016405),-0.5992611467582326,-1.5660607169981455,0.03155339805825243,0.6318761969999861,0.994,5/14,20.86%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3989195044087446,-1.5634283326214407,0.009389671361502348,0.5911191171840103,0.995,23/72,9.31%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;MYO1B;ACTN2;MARK1;KCNJ2;GSDME;COMMD1;SNX21;ANXA2;SYT7;HIP1R;TWF1;RPH3A;FRMPD4;TULP3;LDLRAP1;SLC9A1;CAPG
prerank,tropomyosin binding (GO:0005523),0.6463222721494989,1.557701437541956,0.05612244897959184,1.0,1.0,6/16,9.26%,SMTNL1;SMTNL2;TMOD2;S100A6;TMOD1;CALD1
prerank,calcium-release channel activity (GO:0015278),0.664550257931177,1.5505654247599425,0.04669887278582931,1.0,1.0,4/17,3.58%,ITPR2;ITPR3;TPCN1;FKBP1B
prerank,voltage-gated ion channel activity (GO:0005244),0.6904836094266233,1.5476123839674436,0.04318936877076412,1.0,1.0,3/14,4.79%,VDAC2;ANO6;CACNA1H
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7140839929060449,1.5454018842255868,0.05517241379310345,1.0,1.0,2/11,3.04%,ROR2;STK38
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6613405633857081,1.5412661443044822,0.04966887417218543,1.0,1.0,7/16,15.79%,MTMR7;MTMR6;INPP5F;MTMR3;PTEN;MTMR12;MTMR1
prerank,growth factor activity (GO:0008083),0.503505071409492,1.5372985134393773,0.020100502512562814,1.0,1.0,4/74,2.29%,NGF;FGF7;FGF1;JAG1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5055698790103739,-1.5277104083717936,0.042735042735042736,0.7061829451495759,1.0,9/22,21.63%,PICALM;AP2A1;APOE;DNAJA1;LDLRAP1;ANKRA2;MESD;APBB3;CLU
prerank,kinase activator activity (GO:0019209),-0.4727720533602527,-1.524224265050925,0.027522935779816515,0.6722956751514999,1.0,13/30,27.59%,PRKAG2;MADD;GPRC5C;BCL10;RPLP1;CDK5R1;GPRC5B;WNT11;GPRC5A;NCKAP1L;WNK1;AGAP2;TPX2
prerank,alpha-actinin binding (GO:0051393),0.5991921690899451,1.5197968448498356,0.0631911532385466,1.0,1.0,5/24,7.46%,MAGI1;KCNA5;PDLIM4;DAG1;RARA
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4979217133464613,-1.518818137839637,0.04093567251461988,0.6524461237670526,1.0,10/23,15.52%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;CNP;PDE4A;PDE1B
prerank,transforming growth factor beta binding (GO:0050431),-0.4924398172513705,-1.5166910043116144,0.04225352112676056,0.6207986423848334,1.0,7/23,8.48%,ENG;TGFBR3;TGFBR1;ACVRL1;NRROS;TGFB3;VASN
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4836062520875297,-1.5135824610856257,0.0221606648199446,0.5961695765496726,1.0,9/26,12.98%,SLC16A12;SLC6A6;ABCG2;SLC5A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC6A1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5915596116235182,-1.512389168942001,0.052763819095477386,0.5678697743898421,1.0,8/12,26.21%,SDHB;XDH;AOX1;CIAPIN1;FXN;ISCA2;ISCU;CISD2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.42114915406432535,-1.5118446219817083,0.028268551236749116,0.5400052491678219,1.0,20/47,24.62%,SLC7A11;SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC16A2;SLC6A1;SLC38A7;SLC3A2;SLC22A2;SLC38A5;SLC25A29;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6664646996851809,1.5054911726748301,0.07525083612040134,1.0,1.0,7/14,18.82%,MINDY3;MINDY2;USP13;OTUD7B;MINDY4;USP15;USP9X
prerank,GABA receptor binding (GO:0050811),-0.6122764211233882,-1.503656551815674,0.05239179954441914,0.5414533951363107,1.0,4/11,17.93%,ARFGEF2;GABARAPL1;GABARAP;LHFPL4
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6463857268291394,1.5006719070683112,0.07142857142857142,1.0,1.0,6/14,15.79%,MTMR7;MTMR6;MTMR3;PTEN;MTMR12;MTMR1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5953498538870008,-1.5005607211766419,0.06716417910447761,0.5280660626544943,1.0,5/12,20.34%,SLC6A6;SLC38A7;SLC3A2;SLC38A5;SLC1A4
prerank,syntaxin binding (GO:0019905),-0.397016431017964,-1.5001734180999924,0.008583690987124463,0.5053611619811835,1.0,22/61,21.83%,DAPK1;UNC13C;STXBP3;NAPA;TMED9;STX8;SYT9;LRRK2;RAB11A;GOLGA2;SYPL1;SYNPR;STX6;SCFD1;STXBP4;CPLX2;STX16;BLOC1S6;UNC13A;SNAP47;SYT6;SNAP25
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5850643914089042,-1.49001068983066,0.053738317757009345,0.5199702382942225,1.0,5/12,3.88%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.6053777347907165,1.4896302605026888,0.07207207207207207,1.0,1.0,14/20,30.68%,USP50;UFSP2;USP47;COPS5;USP9X;SENP3;SENP2;OTUB1;SENP5;SENP1;DESI2;OTULINL;OTUD5;EIF3H
prerank,ephrin receptor binding (GO:0046875),0.6041557390902234,1.4871215826817532,0.07086614173228346,1.0,1.0,8/21,16.82%,EFNA5;EFNB1;SRC;EFNB2;ANKS1B;ANKS1A;EFNA3;EFNB3
prerank,protein tyrosine kinase activity (GO:0004713),0.4682487076737124,1.4863342024059911,0.03361344537815126,1.0,1.0,18/108,6.49%,ROR2;PKDCC;ROR1;TEC;NTRK3;FGFR1;EGFR;MUSK;ITK;CLK1;WEE1;TXK;PEAK1;SRC;HIPK1;FER;EPHB2;ABL2
prerank,I-SMAD binding (GO:0070411),-0.5730704434316343,-1.4802234500201779,0.08450704225352113,0.5328584609301201,1.0,5/13,4.13%,SMAD3;SMAD6;SMAD9;TGFBR1;SMAD5
prerank,mechanosensitive ion channel activity (GO:0008381),0.6682677364423406,1.4773261810422564,0.08375209380234507,1.0,1.0,5/12,14.45%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A
prerank,peptidase activator activity (GO:0016504),0.5907365189765093,1.4763220791229053,0.07210031347962383,1.0,1.0,5/22,8.38%,CAV1;APH1B;PSME3;NLRC4;EBAG9
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.6015778068077986,-1.472377583855766,0.04846938775510204,0.5369389951890335,1.0,8/11,27.94%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4;PYCARD;CASP1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.35704874328476155,-1.4719026314260188,0.0106951871657754,0.5178505947381852,1.0,25/91,9.31%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;MYO1B;ACTN2;MARK1;KCNJ2;GSDME;COMMD1;SNX21;ANXA2;SYT7;KCNH1;HIP1R;TWF1;RPH3A;FRMPD4;TULP3;WIPI1;LDLRAP1;SLC9A1;CAPG
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5170342639444532,-1.4679195811910581,0.06315789473684211,0.5109973662949213,1.0,5/18,3.88%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6210425347984394,-1.4607587381498885,0.035443037974683546,0.5144407447739976,1.0,6/10,17.69%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4
prerank,aminopeptidase activity (GO:0004177),0.5708587381568901,1.4544652613278997,0.07794117647058824,1.0,1.0,10/26,12.55%,XPNPEP2;MMP15;RNPEP;LVRN;BLMH;LNPEP;XPNPEP3;KDM8;MMP16;LTA4H
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5290212227824829,1.4506532779786416,0.07290233837689133,1.0,1.0,2/42,0.08%,STXBP6;NTNG1
prerank,amyloid-beta binding (GO:0001540),-0.3588871885354491,-1.4495418335310453,0.014563106796116505,0.5323045293987088,1.0,17/79,12.75%,PICALM;INSR;ITM2A;COL25A1;FZD6;LRP1;EPHA4;GRIA2;LDLR;GRIN2B;APOE;APBB2;LDLRAP1;GRIN1;VBP1;CRYAB;TGFB2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4893306611893086,-1.4479303921860363,0.06628242074927954,0.5193573661972862,1.0,9/21,15.52%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;PDE4A;PDE1B
prerank,voltage-gated anion channel activity (GO:0008308),0.6329317084875941,1.4451416147357696,0.0978441127694859,1.0,1.0,4/15,6.18%,VDAC2;ANO6;CLCN2;CLCN1
prerank,metalloaminopeptidase activity (GO:0070006),0.623610522745134,1.4425067103442233,0.08415841584158416,1.0,1.0,10/16,21.76%,MMP15;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;MMP14;ENPEP;XPNPEP1
prerank,gated channel activity (GO:0022836),0.6267476951582436,1.4419967160333886,0.10094637223974763,1.0,1.0,6/14,15.50%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A;TMEM266
prerank,hexosaminidase activity (GO:0015929),0.6394482209353974,1.4393388575816346,0.10152284263959391,1.0,1.0,6/12,20.31%,NAGA;HEXA;CEMIP2;HEXB;OGA;CEMIP
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5836253868034565,1.4382759547323951,0.1,1.0,1.0,3/21,8.47%,FGF7;FGF1;FGF18
prerank,carbohydrate kinase activity (GO:0019200),0.66507111548381,1.4305776040002576,0.12859560067681894,1.0,1.0,6/11,16.91%,HK2;NAGK;GALK1;GALK2;FGGY;POMK
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6091310125208285,1.42672088663127,0.12980769230769232,1.0,1.0,1/18,0.06%,STXBP6
prerank,ATPase binding (GO:0051117),0.4823303174519391,1.4227046666306606,0.05789473684210526,1.0,1.0,19/71,10.72%,CAV1;EGFR;SLC2A13;SLC26A9;NUFIP1;PDE4D;PGR;SRC;NCSTN;SELENOS;RDX;SNX10;ALDOB;ATP6V0A1;SNU13;ATP1B3;ABCA1;CHMP4A;ANK1
prerank,retinoic acid binding (GO:0001972),0.6412449980538778,1.4198154254276505,0.11012433392539965,1.0,1.0,2/12,7.46%,NR2F2;RARA
prerank,alpha-tubulin binding (GO:0043014),0.5242144053243101,1.4147200057049951,0.12481203007518797,1.0,1.0,11/31,18.20%,DLEC1;TRPV4;RACGAP1;SPAST;FNTA;HDAC6;INO80;ARL8B;TBCE;SETD2;OFD1
prerank,mannose binding (GO:0005537),0.6308849895078257,1.4103316431973354,0.116751269035533,1.0,1.0,2/12,3.61%,COLEC11;LMAN2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5917298865842855,-1.4087642222413264,0.11057692307692307,0.6315412028904065,1.0,4/10,11.33%,NOX4;CYBA;NOX1;NCF2
prerank,histone acetyltransferase binding (GO:0035035),-0.47686239454864054,-1.4061482953560778,0.09090909090909091,0.6213821642758287,1.0,5/21,10.59%,GLI3;HIF1A;MEF2A;CITED2;EPAS1
prerank,androgen receptor binding (GO:0050681),-0.4567197713265333,-1.4057168083172056,0.08746355685131195,0.6037173652120599,1.0,7/25,13.08%,FOXP1;EP300;WIPI1;RNF6;SNW1;KDM1A;ARID5A
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6087508459821238,1.3996101417292701,0.12351945854483926,1.0,1.0,6/15,11.05%,PHLDA3;SESTD1;LANCL2;SH3PXD2B;OBSCN;SAP30L
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5671340715855486,1.3983584373081726,0.11949685534591195,1.0,1.0,5/21,18.62%,CHRNB3;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5309546205154854,-1.3962960752321352,0.07894736842105263,0.617814402402511,1.0,7/14,23.73%,SDHB;NFU1;CIAO3;ISCA2;RSAD2;ISCU;EXO5
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5076866399009362,1.3959428161937568,0.09246088193456614,1.0,1.0,12/38,12.61%,SORBS1;RGS14;AXIN1;CD3G;NUP62;CARD10;TRADD;NCK2;GAB2;LAT;SPAG9;SH2B1
prerank,transcription coactivator binding (GO:0001223),0.5791422994826547,1.3934032204876654,0.12229102167182662,1.0,1.0,3/20,4.11%,RORA;VGLL4;PGR
prerank,protein kinase activator activity (GO:0030295),-0.3726593707064535,-1.390394531350969,0.013452914798206279,0.6198081262337319,1.0,26/60,28.40%,PRKAG2;FAM20A;AFAP1L2;IGF2;MADD;GPRC5C;CALM1;MAP2K2;ABI1;RPLP1;RICTOR;CALM3;CDK5R1;GPRC5B;WNT11;CD24;GPRC5A;NCKAP1L;MAP2K1;ERBB3;WNK1;AGAP2;MLST8;TPX2;DDX3X;PARP16
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6482891682041902,1.3891699971264329,0.1361344537815126,1.0,1.0,4/10,14.78%,DPYS;CAD;DPYSL2;DPYSL5
prerank,peptide hormone receptor binding (GO:0051428),0.6627740446111188,1.3879120814352788,0.12126537785588752,1.0,1.0,2/11,4.00%,GNRH1;PTHLH
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4681058125019748,1.3870356809573132,0.08808290155440414,1.0,1.0,8/60,2.13%,ROR2;ROR1;NTRK3;FGFR1;EFEMP1;EGFR;MUSK;NRP2
prerank,clathrin adaptor activity (GO:0035615),-0.5178658320318985,-1.38387796924386,0.112,0.6247421824847629,1.0,5/15,8.47%,HIP1;DAB2;AP2A1;HIP1R;LDLRAP1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3888634934620273,1.382485220000496,0.001002004008016032,1.0,1.0,85/731,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NEUROD6;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;CREB3L1;HEYL;ZNF697;ZFP1;SP3;BHLHE40;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;MYPOP;PKNOX2;ZNF628;E4F1;FOXK2
prerank,transcription corepressor binding (GO:0001222),0.5433718191619998,1.3815429303881623,0.1109375,0.989163807334995,1.0,1/27,0.04%,RORA
prerank,NADP binding (GO:0050661),-0.41761812038302004,-1.3810313079167695,0.08626198083067092,0.6163772348610117,1.0,15/32,23.37%,DPYD;NOS3;CRYZL1;CAT;NOX1;QDPR;ME1;DHFR;MTRR;PGD;NOS1;DHCR7;CRYZ;ME3;TM7SF2
prerank,pyrophosphatase activity (GO:0016462),-0.37646666982838606,-1.3800377755549786,0.06910569105691057,0.6036542995193659,1.0,32/50,39.36%,ENPP1;ENTPD1;ENPP3;ALPL;PLPP1;NUDT3;LHPP;ENTPD5;TRPM2;PPA1;PLPP4;ENTPD3;NUDT11;DHX29;CILP;DCP2;FITM2;NUDT16;NUDT16L1;CILP2;NUDT22;DDX3X;BNIPL;ENTPD6;PRUNE1;NUDT10;ATCAY;RNGTT;DCTPP1;NUDT14;PLPP5;PRUNE2
prerank,death receptor activity (GO:0005035),-0.5599583892903,-1.379635959859254,0.11161731207289294,0.5894433620098698,1.0,4/11,13.49%,TNFRSF19;FAS;TNFRSF1B;TNFRSF11A
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.387576960490755,1.3793322783941422,0.001002004008016032,0.979095587997281,1.0,85/732,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NEUROD6;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;HEYL;ZNF697;ZFP1;SP3;BHLHE40;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;MYPOP;ISL1;PKNOX2;ZNF628;E4F1;FOXK2
prerank,beta-tubulin binding (GO:0048487),0.521203275444965,1.3791061278531218,0.10762331838565023,0.9609602175250056,1.0,9/31,13.98%,DLEC1;TRPV4;RACGAP1;SMC3;SPAST;IFT74;ARL8B;EMD;HTT
prerank,retinoid binding (GO:0005501),-0.4630264175005736,-1.3786427855233536,0.08493150684931507,0.5778651611344214,1.0,6/22,10.08%,ALDH1A2;RBP1;CYP26B1;RBP4;ABCA4;PTGDS
prerank,solute:proton symporter activity (GO:0015295),-0.49500265610219585,-1.372790419316344,0.104,0.5823364290188233,1.0,8/16,10.34%,SLC39A8;SLC17A5;SLC15A2;SLC11A2;SLC15A4;SLC33A1;SLC2A10;CTNS
prerank,tau protein binding (GO:0048156),-0.3886772286518102,-1.369952500918975,0.052805280528052806,0.5778599306860988,1.0,10/40,12.54%,PICALM;ROCK2;MARK1;EP300;APOE;ACTB;LGMN;GSK3A;TTBK1;TAOK2
prerank,syntaxin-1 binding (GO:0017075),-0.45818771928696683,-1.3690614764029638,0.10778443113772455,0.5678442303398943,1.0,9/22,21.83%,DAPK1;UNC13C;STXBP3;LRRK2;SYPL1;SYNPR;CPLX2;UNC13A;SNAP25
prerank,Wnt-activated receptor activity (GO:0042813),0.5929834704235114,1.3685581304267322,0.1386986301369863,0.9925191505404802,1.0,6/15,14.91%,ROR1;FZD2;PKD1;FZD7;FZD9;FZD3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6382358180963827,1.3678057211091221,0.14904679376083188,0.9773853424599549,1.0,3/10,7.98%,EHHADH;HADHB;HSD17B4
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5927824711811269,1.3654552861823512,0.14035087719298245,0.9698075340997442,1.0,2/18,2.53%,HSD17B3;RDH5
prerank,protein phosphatase 1 binding (GO:0008157),0.5477730457748248,1.363265833005251,0.13132911392405064,0.9619816786974396,1.0,4/21,6.22%,SMTNL1;SH3RF2;SMTNL2;AKAP11
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.45379448258227606,-1.35135549708005,0.09295774647887324,0.6075118177224897,1.0,10/21,30.96%,ARFGEF2;WASF3;AKAP6;AKAP1;PJA2;AKAP8L;AKAP7;ACBD3;KCNQ1;RYR2
prerank,acetylcholine receptor activity (GO:0015464),0.5384871047521891,1.3496114140083133,0.1562021439509954,1.0,1.0,5/22,18.62%,CHRNB3;CHRM2;CHRM3;CHRNA7;CHRFAM7A
prerank,peptidase inhibitor activity (GO:0030414),0.4969707186756314,1.3487404678207764,0.12198581560283688,0.9936304340789175,1.0,2/33,0.61%,GPC3;SPINK1
prerank,acid-thiol ligase activity (GO:0016878),-0.5234089196828726,-1.348651516435567,0.12285012285012285,0.6026034382177701,1.0,5/13,20.86%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5899419148920182,1.3450337376793726,0.171334431630972,0.9923433515001694,1.0,1/13,0.72%,EHHADH
prerank,receptor ligand activity (GO:0048018),0.3948528711952154,1.3408056453757968,0.03270042194092827,0.994497135273363,1.0,28/245,10.21%,NGF;EDA;FGF7;INHBB;IL19;WNT10A;FGF1;JAG1;SEMA4B;INSL6;WNT2B;GNRH1;IL1A;WNT16;PTHLH;NBL1;BMP5;WNT5A;BMP15;APLN;ARTN;SEMA3A;DPP4;FGF18;TAFA5;HMGB1;LEFTY1;C1QTNF12
prerank,telomerase RNA binding (GO:0070034),0.5357885525735893,1.3386671308561942,0.135258358662614,0.986593419495503,1.0,6/22,12.93%,HNRNPC;NAF1;WRAP53;EXOSC10;TEP1;SMG7
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6353511913069634,1.3376337337506166,0.1681109185441941,0.974020328229696,1.0,1/10,0.29%,CXADR
prerank,LRR domain binding (GO:0030275),-0.5150981433334996,-1.3376176191735052,0.13138686131386862,0.6226700911094067,1.0,7/14,19.54%,ROBO1;PAWR;LRRFIP2;ZXDC;ATF4;POLR2J;DAPK3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5521051930550933,-1.3323123811199502,0.16136363636363638,0.626084664220909,1.0,8/10,40.88%,LACC1;CDA;GDA;ADA;DCTD;ADARB2;CDADC1;APOBEC1
prerank,antiporter activity (GO:0015297),0.5432107232604932,1.3302127677464486,0.16905901116427433,0.9914861077871638,1.0,4/20,8.08%,SLC35A1;SLC35D3;SLC35C2;SLC35D2
prerank,GTPase inhibitor activity (GO:0005095),-0.5285713816111524,-1.329440568247649,0.13432835820895522,0.6219885693782357,1.0,7/13,19.55%,SLIT2;TNK2;CPEB2;IQGAP2;RHOH;ARL2;GPS1
prerank,serine-type endopeptidase activity (GO:0004252),0.43351518130263555,1.328908161129624,0.10933660933660934,0.9811737286763992,1.0,16/80,17.96%,CORIN;CTRC;FAP;KLK2;PCSK5;CD5L;DPP4;PCSK7;PROC;CELA1;HTRA2;PLG;TYSND1;MBTPS1;MASP2;RHBDF1
prerank,sequence-specific DNA binding (GO:0043565),0.3741645734122784,1.3280729333374377,0.0050150451354062184,0.9691796415584977,1.0,81/590,11.82%,RORA;MEOX2;KLF5;ETV4;NFATC2;ETV1;PPARGC1A;PAX9;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;MYBBP1A;ETV5;RUNX2;HOXB6;GLI2;TEF;HLX;KLF3;KMT2A;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;HDAC4;SATB1;KLF10;CREB3L1;ZFP1;SP3;BHLHE40;STN1;ONECUT1;SIRT3;CTCF;HIC1;PAX3;HOXC10;TBX2;ONECUT3;RARA;MAFG;USF2;LHX6;ISL1;PKNOX2;FOXK2;UPF2;LIN28B;TBX18;TET1;SLTM;MECP2;RORB;POU4F1;HDAC2;DBP;TLX3;TFEB;LONP1;MMP12;RARG;FBXL19;EN2;EGR1;ZBTB49;ZNF148;ERF
prerank,phosphatase binding (GO:0019902),0.41929572635957335,1.3263254433550302,0.09845788849347568,0.9616347149839769,1.0,20/105,10.73%,NFATC2;PXN;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SPRED1;EIF2AK3;SFI1;MAP3K5;PIK3R2;ELL;ANAPC5;MTMR3;ANAPC7;PTPRT;DLG3;ANK1;TRPC4AP
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.35824981703030706,-1.3247490081283029,0.07518796992481203,0.623148141091194,1.0,9/49,7.39%,ANXA3;DYSF;C2CD5;SYT9;ANXA2;SYT7;RPH3A;MCTP2;ANXA1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3551602798012423,-1.3213725042802784,0.0784313725490196,0.6209002438435007,1.0,13/55,13.08%,SLC16A12;SLC13A3;SLC6A6;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC38A7
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5610226416517302,-1.3208167227789154,0.15468409586056645,0.6105133118909566,1.0,2/10,1.72%,PRKAG2;PKIG
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.39679486750597465,-1.3189483207597839,0.13015873015873017,0.6038844286576103,1.0,7/30,6.86%,SLC30A10;SLC39A10;SLC39A8;ATP7A;SLC31A1;SLC11A2;SLC39A14
prerank,phosphatase activator activity (GO:0019211),-0.5072343285457025,-1.3187235208553276,0.13793103448275862,0.5929670444451721,1.0,9/14,32.61%,FRS2;CALM1;BMP2;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,endopeptidase inhibitor activity (GO:0004866),0.4350821397789976,1.318572224723729,0.11475409836065574,0.9803245445196697,1.0,4/82,1.58%,NGF;SPINK1;SERPINB2;SERPING1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.610180462434367,1.3142776022215361,0.18588640275387264,0.9844324839695959,1.0,2/11,5.38%,ARG1;DDAH2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5725158960003408,1.314055735636096,0.1821247892074199,0.9706627256041677,1.0,2/15,1.67%,ALDH1A3;ALDH9A1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.45669756129535977,1.3125095446783999,0.14540466392318244,0.9626161266306282,1.0,8/48,8.00%,PIEZO2;NALCN;TRPM3;SLC12A2;TRPV4;SLC12A4;SLC4A11;PIEZO1
prerank,cytokine receptor activity (GO:0004896),-0.3235864161037272,-1.3115695987374718,0.058823529411764705,0.6019199929702775,1.0,14/83,8.25%,IL1R1;OSMR;IL31RA;GHR;IL13RA1;IL6R;IFNAR2;IL1RAP;IL10RB;F3;LIFR;CNTFR;IL15RA;CMKLR1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3662220335500559,1.3048256021528006,0.004004004004004004,0.980470319011342,1.0,90/831,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NPAS3;NEUROD6;ETV5;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;ZBTB8A;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;HEYL;ZFP3;ZNF697;ZFP1;SP3;BHLHE40;ZFP90;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;LHX6;MYPOP;PKNOX2;ZNF628;E4F1;FOXK2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.538125575173289,1.3026711787157228,0.196875,0.976197844171819,1.0,4/20,3.57%,MPP1;CASK;TJP2;MAGI3
prerank,platelet-derived growth factor binding (GO:0048407),-0.5376870171613294,-1.3018836390904922,0.16009852216748768,0.6200534818095943,1.0,3/11,1.97%,PDGFRB;PDGFRA;COL5A1
prerank,endopeptidase activator activity (GO:0061133),0.6034129120780445,1.2969239915287871,0.2014519056261343,0.9864682413582913,1.0,3/10,6.99%,APH1B;PSME3;NLRC4
prerank,cGMP binding (GO:0030553),-0.5295769426563435,-1.2929663784433854,0.1769041769041769,0.635107187577476,1.0,4/11,9.40%,RAPGEF2;PDE5A;PDE10A;PDE2A
prerank,BMP binding (GO:0036122),-0.5178788610474035,-1.2889578484010635,0.18777292576419213,0.6355462699498245,1.0,3/11,6.66%,ENG;BMPR2;GREM2
prerank,SH2 domain binding (GO:0042169),0.4879293003584103,1.286011960147757,0.17612809315866085,1.0,1.0,6/31,7.06%,DLC1;TRPV4;SRC;NUP62;SH3PXD2B;DAG1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5910071239107157,1.285262035785008,0.18914185639229422,1.0,1.0,3/11,12.99%,CNGB1;CNGA4;AQP1
prerank,myosin II binding (GO:0045159),-0.53700394485297,-1.2844451592388977,0.19271948608137046,0.63793974588462,1.0,5/10,28.08%,TRIOBP;LLGL2;MYL4;SHROOM1;STXBP5
prerank,sialyltransferase activity (GO:0008373),-0.42873262789776145,-1.2827632913624343,0.1634349030470914,0.6324143932079774,1.0,6/20,5.46%,ST3GAL6;ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3;ST6GALNAC2
prerank,vinculin binding (GO:0017166),0.5770398734851031,1.2822754017781246,0.21150592216582065,1.0,1.0,3/11,7.06%,UTRN;PXN;DAG1
prerank,zinc ion binding (GO:0008270),-0.261268007393322,-1.2799540870127348,0.02127659574468085,0.6303134816897696,1.0,52/293,10.98%,SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;PAPPA;ENPP2;PHF8;KDM2B;CHD4;SAMHD1;PDXK;UBA5;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;LITAF;NAPEPLD;RPS29;ENPP3;CXXC5;ACE;RPS27;GRIN2B;BLM;KLF4;RNF125;RBSN;UPB1;ARIH1;RPH3A;ZFP37;MNAT1;GCH1;ZCCHC4;RNF11;PRDM2;PDE2A;USP33;TRIM28;TES;SEC23A;BMI1
prerank,transaminase activity (GO:0008483),0.5795677811784513,1.2762725612527728,0.22837370242214533,1.0,1.0,4/11,13.15%,AADAT;ABAT;BCAT2;GOT1
prerank,protein phosphatase binding (GO:0019903),0.3999014633296516,1.2760480575245818,0.12838633686690223,1.0,1.0,31/117,16.35%,PXN;SMTNL1;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SMTNL2;EIF2AK3;ATP2B4;AKAP11;MAP3K5;PIK3R2;BOD1L1;ANAPC5;MTMR3;ANAPC7;MASTL;PTPRT;ANK1;STRN;ENSA;MVP;PTPA;SMG7;ANAPC4;BAD;ADCY8;ERBB2;TBK1;AP3B1
prerank,NAD binding (GO:0051287),-0.40935299423778365,-1.2750570465042876,0.1569767441860465,0.6339174749467099,1.0,10/26,22.07%,ALDH1A1;CRYL1;BDH2;QDPR;ZC3HAV1;ME1;HADH;CRYZ;SORD;ALDH2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4938970897490123,1.2748663369030326,0.1883614088820827,1.0,1.0,9/27,12.99%,ITPR2;SLC12A2;SLC12A3;ATP2B4;CNNM2;MRS2;ZDHHC13;TUSC3;AQP1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5632311850609084,1.2696010870112628,0.19230769230769232,1.0,1.0,1/14,0.03%,NGF
prerank,alkali metal ion binding (GO:0031420),0.5783780710479438,1.267600938811666,0.1875,1.0,1.0,4/13,7.77%,TDG;HDAC4;ATP1A2;ACAT1
prerank,Tat protein binding (GO:0030957),0.5764017022148112,1.2652302380612344,0.22284644194756553,1.0,1.0,1/10,0.33%,MDFIC
prerank,voltage-gated chloride channel activity (GO:0005247),0.5898521251875928,1.2640974034896666,0.21863799283154123,0.9950610889917528,1.0,3/10,6.18%,ANO6;CLCN2;CLCN1
prerank,channel activity (GO:0015267),0.4552975504458309,1.2638015447073272,0.15310344827586206,0.9841680134342534,1.0,9/41,19.72%,CHRNB3;TRPV4;MPV17;PANX2;AQP1;TRPV2;TMEM266;CHRNA7;BAX
prerank,ephrin receptor activity (GO:0005003),-0.45145154945757565,-1.2607850518512826,0.16321243523316062,0.6555320882774146,1.0,7/17,18.50%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.45145154945757565,-1.2607850518512826,0.16321243523316062,0.6555320882774146,1.0,7/17,18.50%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5095766345632969,-1.259168830161732,0.18925831202046037,0.6504209595571275,1.0,10/12,28.18%,PDE7B;PDE8A;PDE8B;PDE2A;PDE4A;PDE1B;PDE4C;PDE4B;PDE3B;PDE7A
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4145174779492308,1.2589463707976136,0.14856429463171036,0.9925593936942864,1.0,22/71,15.20%,UBASH3B;PTPN13;PTPRF;EYA1;PTPDC1;PTPN14;TPTE;PTPN22;PTPRC;PTP4A2;PTPRJ;MTMR6;MTMR3;PTPRT;HACD2;PTPN18;PTEN;PTPRA;PALD1;PTPRU;PTPRO;PTPN6
prerank,serine-type peptidase activity (GO:0008236),0.4007430225487004,1.2586017812040406,0.1392857142857143,0.9820347651571554,1.0,22/96,20.97%,CORIN;CTRC;FAP;KLK2;NAALAD2;PCSK5;CD5L;DPP4;PCSK7;PROC;CELA1;HTRA2;PLG;TYSND1;MBTPS1;MASP2;TMPRSS7;RHBDF1;GZMK;HGF;PLAT;PRSS8
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5589824019649168,1.256822198439301,0.2193877551020408,0.9775685715972208,1.0,2/13,1.67%,ALDH1A3;ALDH9A1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5765813452095219,1.2520292076089161,0.20869565217391303,0.9858324946044073,1.0,8/13,24.56%,TARBP1;WDR4;FTSJ1;TRMT5;THUMPD3;TRMT1L;TRMT1;THUMPD2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4920648349951991,-1.250940239983013,0.19839142091152814,0.6638863212752186,1.0,6/14,25.02%,NOX4;CYBA;NOX1;NCF2;AIFM1;KMO
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.39579884037697927,-1.2501004212869007,0.15822784810126583,0.6566067076600677,1.0,7/24,13.57%,DAPK1;MKNK2;CAMK2A;MKNK1;CAMK4;MAPKAPK2;MAPKAPK3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5198556342043683,-1.2498599444518463,0.19389978213507625,0.6474131834183796,1.0,3/10,7.01%,MECOM;SETD5;PRDM16
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5181606933276299,-1.2456626114334703,0.21100917431192662,0.6507500739800763,1.0,6/10,37.88%,TATDN1;DCLRE1B;DCLRE1C;EXO1;MGME1;FEN1
prerank,AMP binding (GO:0016208),-0.4974176309759747,-1.2431461984463381,0.2100238663484487,0.6481480597106161,1.0,2/11,2.26%,PRKAG2;MPPED2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.499442039768808,1.2400016327612187,0.22820919175911253,1.0,1.0,6/20,11.28%,MOGAT2;MOGAT3;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,double-stranded DNA binding (GO:0003690),0.3484789262664362,1.2371503997074489,0.04934541792547835,1.0,1.0,66/531,11.92%,MEOX2;KLF5;ETV4;NFATC2;ETV1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;EGFR;BHLHE22;ZBTB20;ETV5;RUNX2;TDG;MSH6;HOXB6;GLI2;TEF;KLF3;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;SATB1;KLF10;NTHL1;CREB3L1;ZFP1;SP3;BHLHE40;ONECUT1;HIC1;PAX3;HOXC10;TBX2;ONECUT3;MSH2;RARA;MAFG;USF2;LHX6;ISL1;PKNOX2;LIN28B;TBX18;MECP2;HMGB1;RORB;POU4F1;DBP;TLX3;TFEB;RARG;EN2;EGR1;TDP1;TOP1;MEN1
prerank,transition metal ion binding (GO:0046914),-0.24382454206016985,-1.2327780489521627,0.0,0.6696124551619818,1.0,78/397,13.44%,MOXD1;SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;NOS3;PAPPA;MPPED2;ENPP2;PHF8;KDM2B;FTH1;ATP7A;CHD4;SAMHD1;WRN;PDXK;UBA5;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;COMMD1;LITAF;HMGCL;NAPEPLD;LACC1;RPS29;ENPP3;CXXC5;ACE;FTL;SOD3;RPS27;AOX1;GRIN2B;BLM;KLF4;SLC11A2;RNF125;RBSN;UPB1;ARIH1;RPH3A;ZFP37;MNAT1;GCH1;ADCY2;ZCCHC4;RNF11;PRDM2;PDE2A;USP33;TRIM28;TES;SEC23A;B4GALT1;BMI1;B4GALT7;ETHE1;DPP3;LOXL3;NUDT12;NFU1;ABCE1;KDM7A;CALB1;ME1;ADH1A
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42152536043900146,1.2315025155265842,0.19160104986876642,1.0,1.0,6/60,1.81%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK
prerank,store-operated calcium channel activity (GO:0015279),-0.514258929604493,-1.2312999765410861,0.2350230414746544,0.66469863313357,1.0,5/10,18.97%,TRPC3;TRPC1;ORAI1;TRPC7;STIM2
prerank,cell adhesion mediator activity (GO:0098631),0.4918383280784907,1.229003694199251,0.22910216718266255,1.0,1.0,2/24,4.59%,NTNG1;DSCAM
prerank,ribosome binding (GO:0043022),-0.34435395617211473,-1.228860219881775,0.12692307692307692,0.6618129849715273,1.0,22/46,25.11%,CPEB4;EIF3C;NOMO1;NAA15;CPEB2;SEC61B;ZC3H12A;EIF2A;YTHDF1;SERBP1;NCLN;CPEB1;MRPS27;RACK1;MAIP1;SHFL;TMCO1;C1QBP;EEF2;OXA1L;YTHDF3;GEMIN5
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4812671926681027,-1.228545013073606,0.21513002364066194,0.6534391924485854,1.0,3/12,13.66%,POU2F1;HDAC1;TBPL1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5215742762777623,1.2282619166020052,0.22380952380952382,1.0,1.0,1/19,0.26%,EFNA5
prerank,chemokine activity (GO:0008009),-0.3729747912486041,-1.2271939515857224,0.1650485436893204,0.6483048809667293,1.0,24/31,52.22%,CXCL16;CXCL12;CCL13;CCL19;CCL2;CXCL10;CCL25;CCL28;CCL5;CXCL5;CCL11;CCL15;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,diacylglycerol kinase activity (GO:0004143),0.5745124580410608,1.2266954758140198,0.24102564102564103,1.0,1.0,2/11,3.58%,DGKA;DGKZ
prerank,active ion transmembrane transporter activity (GO:0022853),-0.37252805910681674,-1.2254960965184294,0.1639871382636656,0.6443326523289618,1.0,7/37,8.23%,SLC22A8;SLCO3A1;SLCO1C1;SLC22A6;SLC22A4;COX6B1;SLCO2A1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.569759742700403,1.2246249540628806,0.2605633802816901,1.0,1.0,7/10,29.80%,TNFAIP3;STAMBPL1;STAMBP;CYLD;OTUD4;DESI2;OTUD5
prerank,anion transmembrane transporter activity (GO:0008509),-0.47376710168785996,-1.22377153555713,0.23488372093023255,0.6407684596698574,1.0,3/12,3.59%,ABCG2;SLC39A8;SLC22A6
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3980560094808786,-1.2191400557819205,0.17592592592592593,0.6457986994442697,1.0,11/27,22.66%,MED21;POLR3B;TENT2;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F
prerank,ATPase activator activity (GO:0001671),-0.41366184199344236,-1.2183898575981997,0.19021739130434784,0.6398568369966187,1.0,5/20,10.37%,DNAJC1;DNAJB2;DNAJA1;ATP1B1;ATP1B2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4797974757740635,-1.2176229159278915,0.21975308641975308,0.6336760971914757,1.0,4/12,13.15%,PIK3R3;PIK3R6;PIK3C2A;IPMK
prerank,glutamate receptor binding (GO:0035254),-0.4283093566692701,-1.2159302074558243,0.21409921671018275,0.6302860218360757,1.0,6/17,8.50%,HIP1;SHANK3;GNAS;SQSTM1;IGSF11;CAMK2A
prerank,phosphate ion binding (GO:0042301),-0.5135500057422777,-1.21480610245485,0.2107843137254902,0.6255964890441286,1.0,2/10,9.40%,RPH3A;PDE2A
prerank,ion gated channel activity (GO:0022839),-0.38986671912657717,-1.2135830537571743,0.2034383954154728,0.6216509024781379,1.0,9/24,17.70%,ANO1;ANO4;ANO3;KCNT1;TTYH2;TMEM63B;TTYH3;ANO5;TTYH1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.42762118339006705,1.2114045592010696,0.22602739726027396,1.0,1.0,12/46,14.78%,MGAT3;OGT;B3GALT1;GCNT4;B4GAT1;B3GLCT;EXTL2;GCNT2;PIGA;HEXA;HEXB;EXT1
prerank,cadherin binding (GO:0045296),0.35090706768579616,1.20980858948544,0.12280701754385964,1.0,1.0,92/315,20.20%,STXBP6;AHNAK;ITGA6;DOCK9;FMNL2;CDH13;F11R;PARVA;ARHGAP18;CDH11;PLCB3;EGFR;CDH5;CAPZB;CDH17;STK38;PFKP;CDH9;GIGYF2;TJP2;ADD1;EXOC3;SRC;ATIC;LRRC59;USP8;ZC3H15;PACSIN2;RDX;CKAP5;BAG3;CDH2;PTPRJ;PKP4;CHMP5;STK24;CALD1;SFN;FLNB;PTPRT;CGN;IST1;DIAPH3;TBC1D2;SH3GLB2;COBLL1;CHMP4B;APC;SNX2;NOP56;EMD;CTTN;CEMIP2;AHSA1;DDX6;KIF5B;RTN4;BZW1;PTPRO;CTNNA1;GLOD4;RAN;CDH1;SNX5;EZR;SNX1;YWHAE;TNKS1BP1;PPP1CA;MB21D2;SCRIB;UBFD1;SPTBN1;STX5;EHD1;KLC2;CDH15;CDH3;PSMB6;PRDX6;CDH22;MRE11;GCN1;BAIAP2;TBC1D10A;UNC45A;MRTFB;ARGLU1;LYPLA2;ACVR1;EIF4G2;GOLGA3
prerank,transcription coregulator binding (GO:0001221),0.4236592402937675,1.2091921390138072,0.2194787379972565,1.0,1.0,8/50,11.64%,RORA;VGLL4;UBE2I;PGR;CTCF;CHD6;HDAC6;ZBTB49
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5685056229736307,1.2076708829194356,0.2411467116357504,1.0,1.0,3/11,7.80%,EGFR;MAP3K1;MAP3K5
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.48127748735721043,1.2073915854785997,0.2368024132730015,1.0,1.0,6/25,11.64%,POR;FMO4;FMO2;FMO1;MICAL3;MSMO1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3282490677680734,-1.2049341971948102,0.15767634854771784,0.6381140651885016,1.0,13/51,13.12%,SLC22A8;SLCO3A1;SLC7A5;SLCO1C1;SLC22A6;SLC22A4;SLC5A6;SLCO2A1;SLC25A30;SLC25A11;SLC16A2;TMEM241;MFSD2A
prerank,protein kinase inhibitor activity (GO:0004860),0.4181882805447193,1.195316514860857,0.23076923076923078,1.0,1.0,18/42,22.31%,PARVA;SPRED1;SPRY4;IBTK;GMFB;MAPK8IP1;HEXIM1;SPRED2;CDKN1C;CIT;SOCS1;INKA2;RPTOR;CEP43;NCK1;GSKIP;YWHAB;TAOK3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4985350532458934,1.1943209299393733,0.2665589660743134,1.0,1.0,11/18,20.74%,SOCS5;WDR81;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;WDR91;SOCS2;CISH
prerank,serotonin receptor activity (GO:0099589),0.479768761940556,1.1935769183437877,0.27044025157232704,1.0,1.0,1/22,0.35%,HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.479768761940556,1.1935769183437877,0.27044025157232704,1.0,1.0,1/22,0.35%,HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.479768761940556,1.1935769183437877,0.27044025157232704,1.0,1.0,1/22,0.35%,HRH1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.36914664929364194,-1.1934952887823878,0.21003134796238246,0.661795550143785,1.0,14/32,24.62%,SLC6A6;SLC6A9;SLC7A5;SLC25A38;SLC43A2;SLC38A7;SLC1A1;SLC3A2;SLC38A5;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.44426994599226577,-1.1847871441061186,0.2356020942408377,0.6708378397294784,1.0,4/16,3.27%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.44426994599226577,-1.1847871441061186,0.2356020942408377,0.6708378397294784,1.0,4/16,3.27%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.38633859619819394,1.1846585152961588,0.24029126213592233,1.0,1.0,11/75,10.76%,RDH10;EHHADH;RDH5;MDH1B;HADHB;DHRS4;HSD17B4;ADH5;MDH1;AKR1B10;KCNAB1
prerank,C-C chemokine receptor activity (GO:0016493),0.4840526211036469,1.183397830582876,0.25,1.0,1.0,1/21,0.78%,ACKR3
prerank,hydro-lyase activity (GO:0016836),0.42142055306138937,1.1766790358581647,0.2482758620689655,1.0,1.0,12/41,17.95%,EHHADH;CYP2S1;HADHB;HACD4;HSD17B4;HACD2;NAXD;ENO3;GMDS;PCBD2;ENO2;CDYL
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3316890838053081,1.176556820235671,0.09879032258064516,1.0,1.0,65/597,10.25%,MEOX2;BNC2;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;ETV5;RUNX2;HOXB6;GLI2;TEF;CHD3;KLF3;SPI1;FOXK1;BEND3;FOXO3;SOX9;NPAS2;GLIS2;HDAC4;KLF10;CREB3L1;ZFP1;SP3;BHLHE40;ONECUT1;ORC5;CTCF;HIC1;NCOR1;PAX3;HOXC10;TBX2;ONECUT3;RARA;SUV39H1;MAFG;USF2;LHX6;ISL1;PKNOX2;FOXK2;LIN28B;TBX18;FOXJ1;HMGB1;RORB;POU4F1;DBP;ORC3;TLX3
prerank,exopeptidase activity (GO:0008238),0.41484908279748484,1.1750360188073656,0.2643524699599466,1.0,1.0,13/50,12.55%,XPNPEP2;FAP;NAALAD2;CPE;CPA2;RNPEP;DPP4;BLMH;LNPEP;MME;XPNPEP3;KDM8;LTA4H
prerank,pre-mRNA binding (GO:0036002),0.45154710739076886,1.1732808303765592,0.2650957290132548,1.0,1.0,8/28,17.58%,RNPC3;CELF1;ZRSR2;RBM22;CELF2;CELF4;TRA2B;SLU7
prerank,GTPase activator activity (GO:0005096),0.33783376884114036,1.1691009952202804,0.16614745586708204,1.0,1.0,39/313,6.44%,ARHGAP42;SIPA1L1;DOCK9;DLC1;ARHGEF28;RGS6;DOCK5;RGS14;ARHGAP31;PLCE1;ARHGAP18;ARHGAP32;GRTP1;RAPGEF3;PSD;RAP1A;ARHGAP9;RGL1;ARAP1;RAB3IL1;DOCK1;DENND2D;SGSM2;DENND2C;NF1;AKAP13;EIF2B3;OPHN1;RACGAP1;VAV2;GNAQ;WDR41;NUCB1;HPS1;DOCK2;RAPGEF4;ARHGEF5;ARHGAP26;RAB3GAP2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.5018937704012454,1.1660882147596376,0.30363036303630364,1.0,1.0,5/16,13.33%,TDG;NTHL1;SARM1;OARD1;ADPRS
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5347757727844461,1.1636176033893917,0.3046471600688468,1.0,1.0,5/11,19.36%,HSPH1;SIL1;BAG3;BAG2;GRPEL2
prerank,adenyl nucleotide binding (GO:0030554),0.5347757727844461,1.1636176033893917,0.3046471600688468,1.0,1.0,5/11,19.36%,HSPH1;SIL1;BAG3;BAG2;GRPEL2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4995771562586648,1.1612641412859253,0.27347611202635913,1.0,1.0,5/15,13.00%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44954001814759814,1.1565523033748637,0.30280649926144754,1.0,1.0,1/28,0.24%,EDA
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.33677301768908624,1.1554236646827023,0.1940928270042194,1.0,1.0,30/254,10.16%,MEOX2;KLF5;ETV4;ETV1;FOXD2;POU4F3;NFATC1;ETV5;NFIA;FOXO3;SOX9;PGR;GLIS2;ZNF585B;ZNF585A;REL;KLF10;CREB3L1;ONECUT1;NRF1;HOXC10;ZFP62;RREB1;E4F1;FOXK2;PLSCR1;FOXJ1;SMARCD2;POU4F1;DBP
prerank,phospholipase C activity (GO:0004629),0.4550898944689168,1.154909653575702,0.2912912912912913,1.0,1.0,4/25,3.86%,PLCD3;PLCE1;PLCB3;PLCL1
prerank,dynactin binding (GO:0034452),0.518007871513307,1.1527266225156334,0.30687830687830686,1.0,1.0,5/12,15.49%,PAFAH1B1;GSK3B;HOOK3;HTT;SNX5
prerank,fatty acid synthase activity (GO:0004312),0.542665460491023,1.1514990078037353,0.3167808219178082,1.0,1.0,4/10,13.29%,ELOVL5;ELOVL1;ELOVL2;ELOVL6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.41941623587693233,-1.1497076271615885,0.27970297029702973,0.7557950276695472,1.0,8/16,21.29%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.41941623587693233,-1.1497076271615885,0.27970297029702973,0.7557950276695472,1.0,8/16,21.29%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,cytokine receptor binding (GO:0005126),-0.28490019374608505,-1.1489469635861138,0.193717277486911,0.7493763219296984,1.0,14/83,9.58%,SMAD3;OSMR;IL13RA1;TGFBR3;IL6R;FKBP1A;IL1RAP;IL18;LIFR;CXCL12;TRAF6;JAK2;VEGFC;IL34
prerank,regulatory RNA binding (GO:0061980),0.42033998228387953,1.1475612091439975,0.260806916426513,1.0,1.0,17/38,25.77%,DND1;PIWIL2;RBM10;ZNF346;TLR7;AGO1;PUM2;DICER1;SPOUT1;DHX9;PUM1;ELAVL1;ZC3H7B;DDX21;FMR1;PNPT1;AGO2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.44178936146758985,-1.1473962397293807,0.2827763496143959,0.7461025314323791,1.0,5/13,16.27%,PIP5K1B;PIK3C2A;PIP4K2A;PIP4K2C;PIP5K1A
prerank,sodium channel regulator activity (GO:0017080),0.4116402275075076,1.1469619085986273,0.2896551724137931,1.0,1.0,8/37,11.96%,NEDD4L;CAMK2D;GPLD1;ATP2B4;FXYD6;SCN2B;NEDD4;SGK1
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4192886106823108,-1.1451909679827768,0.27835051546391754,0.7442404918295167,1.0,4/16,7.16%,WRN;BLM;NAV2;MCM6
prerank,glutathione transferase activity (GO:0004364),0.4492642684572509,1.1430372260344681,0.29457364341085274,1.0,1.0,6/23,12.23%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1;LANCL1
prerank,mRNA methyltransferase activity (GO:0008174),-0.4685174417596695,-1.1429834802839975,0.2887323943661972,0.7428487377540991,1.0,8/12,36.62%,NSUN2;TRMT61B;METTL16;METTL8;CMTR2;METTL14;TRMT61A;TRMT10C
prerank,adenyl ribonucleotide binding (GO:0032559),-0.23925313903979237,-1.1417500008483281,0.06451612903225806,0.7379555176353676,1.0,69/291,16.55%,PRKAG2;DAPK1;KSR1;RAPGEF2;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;MPPED2;MTHFS;MYO6;SNRK;TGFBR1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;BLM;SMC4;TRNT1;HSPA8;TWF1;HARS1;ABCC6;MCM6;ABCD4;PDE10A;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;PDE2A;CDKL5;VPS4A;TRIB1;MKNK1;OXSR1;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PDE4A;PXK;SMARCA5;ME1;SPHK1;MYO18A;SYN3;MTHFD1L;ABCG1;MVK;MTPAP;P2RX7;HACL1;PEX6;P2RX4;EIF4G1;NOL9;PEX1
prerank,inward rectifier potassium channel activity (GO:0005242),0.447485025803861,1.1415978320848976,0.29249617151607965,1.0,1.0,4/24,5.58%,KCNJ4;KCNJ16;KCNK1;KCNJ13
prerank,C-C chemokine binding (GO:0019957),0.46604560252139887,1.1390685667075107,0.28837209302325584,1.0,1.0,1/22,0.78%,ACKR3
prerank,cation:chloride symporter activity (GO:0015377),0.5367691947794735,1.1389333345697263,0.3258620689655172,1.0,1.0,3/10,4.35%,SLC12A2;SLC12A4;SLC12A3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3497810742315785,1.1377643839953273,0.26262626262626265,1.0,1.0,25/147,8.68%,DOCK9;ARHGEF28;DOCK5;PLCE1;RAPGEF3;PSD;RAP1A;RGL1;RAB3IL1;DOCK1;DENND2D;DENND2C;AKAP13;EIF2B3;VAV2;WDR41;NUCB1;HPS1;DOCK2;RAPGEF4;ARHGEF5;RAB3GAP2;FRMD7;KALRN;RAPGEF6
prerank,myosin binding (GO:0017022),-0.3057910491156038,-1.1344581365287572,0.252,0.7509276756530888,1.0,12/55,18.81%,MYRIP;DMD;RAB6B;RAB3C;LARP6;TRIOBP;RAB11A;NKD2;LLGL2;RAB3B;RAB11B;MLPH
prerank,monocarboxylic acid binding (GO:0033293),0.4690402822300999,1.1335511777009177,0.31862745098039214,1.0,1.0,2/18,7.46%,NR2F2;RARA
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.45133794783139713,1.1324472507005248,0.31458966565349544,1.0,1.0,3/23,1.51%,PLCD3;PLCE1;PLCB3
prerank,metalloendopeptidase activity (GO:0004222),0.36571812483646554,1.1322674932344847,0.288265306122449,1.0,1.0,19/76,16.92%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;MMP15;ADAMTS19;ADAM10;ADAMTS2;MMP12;MME;MMP16;ADAMTSL4;MIPEP;NLN;ZMPSTE24;ADAMTS20;MMP14
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.30706640921282974,-1.1313861652328943,0.22692307692307692,0.7519259474227626,1.0,22/53,24.62%,SLC7A11;SLC47A1;SLC6A9;SLC7A5;SLC7A1;SLC7A6;SLC15A4;SLC25A38;CTNS;SLC43A2;SLC1A3;SLC38A7;SLC1A1;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,hormone activity (GO:0005179),0.39647569143550826,1.1270678517856187,0.3032679738562091,1.0,1.0,5/54,5.62%,INHBB;INSL6;GNRH1;PTHLH;APLN
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4667082907473065,1.1259943139075383,0.30906148867313915,1.0,1.0,4/18,9.05%,ALDH1A3;ALDH9A1;ALDH18A1;AKR1B10
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4229183396641725,1.1258200375745508,0.3191800878477306,1.0,1.0,9/31,15.27%,SLC12A2;SLC12A4;SLC12A3;KCNK1;KCNK5;AQP1;KCNK10;KCNK4;SLC12A8
prerank,ATP binding (GO:0005524),-0.23595551283219823,-1.1253937003935184,0.08823529411764706,0.7617020166516553,1.0,62/266,16.55%,PRKAG2;DAPK1;KSR1;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;MTHFS;SNRK;TGFBR1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;BLM;SMC4;TRNT1;HSPA8;TWF1;HARS1;ABCC6;MCM6;ABCD4;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;CDKL5;VPS4A;TRIB1;MKNK1;OXSR1;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PXK;SMARCA5;SPHK1;MYO18A;SYN3;MTHFD1L;ABCG1;MVK;MTPAP;P2RX7;HACL1;PEX6;P2RX4;EIF4G1;NOL9;PEX1
prerank,RNA polymerase binding (GO:0070063),-0.3927022011167862,-1.123710407870972,0.3064935064935065,0.758537410059071,1.0,11/18,25.26%,YTHDC2;CCNT2;CCNT1;PHRF1;STOM;PPIB;ZFP36;SCAF8;ANP32B;BRCA1;TCERG1L
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5079214018473382,1.1235992511786816,0.3516295025728988,1.0,1.0,2/12,4.76%,B3GALT1;B4GAT1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.44785550769991733,-1.123375201955661,0.3073170731707317,0.7517723374141291,1.0,6/12,27.94%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,frizzled binding (GO:0005109),0.40872374068938333,1.1214293953236625,0.3161764705882353,1.0,1.0,8/34,14.10%,WNT10A;WNT2B;WNT16;WNT5A;ZNRF3;DVL3;WNT9A;FZD7
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.45487990565271813,-1.1204723542187405,0.2899543378995434,0.7524221809936096,1.0,6/11,29.19%,LEF1;GATA2;ZXDC;EHMT2;THAP7;TAF9
prerank,calcium channel regulator activity (GO:0005246),-0.3272732796872947,-1.114288834671751,0.2736842105263158,0.7623953779574262,1.0,9/37,15.44%,ITPR1;PRKG1;FKBP1A;CALM1;CACNG7;NRXN1;REM1;NRXN2;SRI
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3633838779245453,-1.1122108474784203,0.31210191082802546,0.7610348917407502,1.0,11/24,24.74%,LARP6;RPS7;RPL26;RPL41;MYH10;NCL;DHX36;MRPS11;GNL3;RPL5;RPS14
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4856597316293734,1.1121407928374722,0.34071550255536626,1.0,1.0,8/14,25.74%,POP4;POP7;TSEN34;RPP14;RPP21;RPP30;PRORP;TSEN2
prerank,SUMO transferase activity (GO:0019789),0.48123647421166066,1.1104842582943646,0.3475409836065574,1.0,1.0,4/16,11.54%,UBE2I;HDAC4;PIAS2;RANBP2
prerank,leak channel activity (GO:0022840),0.4622592872799586,1.1088431719960654,0.3467094703049759,1.0,1.0,5/18,13.89%,NALCN;KCNK1;KCNK5;KCNK10;KCNK4
prerank,PDZ domain binding (GO:0030165),0.3709328932230529,1.1071085365215554,0.3198433420365535,1.0,1.0,4/61,1.66%,CXADR;F11R;KCNJ4;FZD2
prerank,glycine binding (GO:0016594),-0.44813578701088286,-1.1070004052166125,0.30663615560640733,0.7678636578420389,1.0,4/11,11.74%,GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,peptidoglycan binding (GO:0042834),-0.4642845219328956,-1.1058139649508503,0.32281553398058255,0.7641730702334546,1.0,6/10,39.97%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,manganese ion binding (GO:0030145),0.38748206380606176,1.1039230470932424,0.3319559228650138,1.0,1.0,5/48,6.49%,FAM20C;ARG1;XYLT2;PPM1M;ABL2
prerank,chemoattractant activity (GO:0042056),0.43589636803349013,1.1032882495683973,0.3498452012383901,1.0,1.0,1/26,0.26%,FGF7
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.32844050695926674,-1.1022720992374917,0.289198606271777,0.7668058529199542,1.0,7/35,4.50%,PLCB4;GPCPD1;ENPP1;MPPED2;ENPP2;NAPEPLD;ENPP3
prerank,calcium channel inhibitor activity (GO:0019855),-0.4463040860189087,-1.1010839892751803,0.33867276887871856,0.7627039744084624,1.0,3/11,6.63%,ITPR1;FKBP1A;CALM1
prerank,DNA-binding transcription factor binding (GO:0140297),-0.23466957310821654,-1.1008428493583682,0.1797752808988764,0.7561096620137585,1.0,44/189,16.94%,SMAD3;RUNX1T1;RBPJ;MEF2D;PPARD;TBX3;LMO2;CHD4;PRDM5;EP300;CRTC3;CXXC5;RBL1;SIK1;NPM1;KLF4;HIRA;HDAC7;HDAC9;HDAC1;MEF2A;PRDM16;PTMA;CREB1;MAP3K10;PIAS3;AR;NFYB;ATF2;CRTC2;KDM1A;SP1;BBS2;NOC2L;TAL1;YWHAZ;ID2;MKKS;TLE5;RBL2;MYOCD;HHEX;MTDH;DDX20
prerank,GDP binding (GO:0019003),0.36535048781467044,1.098747531777503,0.3351063829787234,1.0,1.0,21/63,23.21%,RAP1A;RAB8B;RAB29;MRAS;RASEF;NRAS;KRAS;ARF6;MIEF1;ARL8B;RAN;GEM;RAB21;RAB27B;RAB5A;RALA;RAB18;RHEBL1;GNAI3;ARL3;RAB9A
prerank,actin monomer binding (GO:0003785),0.4429202782753104,1.09752182870788,0.3522388059701492,1.0,1.0,4/22,10.66%,PRKCE;COBL;ABL2;MTSS1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4487225281866359,-1.0970043698003773,0.3795811518324607,0.7598013200028662,1.0,3/10,12.83%,PHF8;KDM2B;KDM7A
prerank,nucleotide diphosphatase activity (GO:0004551),-0.4123490298091205,-1.09264867476423,0.3566084788029925,0.7651739083386015,1.0,7/14,21.53%,ENPP1;NUDT13;NUDT3;ENPP4;NUDT12;NUDT11;CILP
prerank,calcium channel activity (GO:0005262),-0.26896690339019513,-1.0924873993270954,0.23728813559322035,0.7586275837203073,1.0,26/84,26.28%,CACNA2D3;SLC24A3;TRPC3;TRPC1;ANXA2;CACNB2;ORAI1;GRIN1;CACNG7;TRPC7;TRPM7;P2RX4;ANXA6;CACHD1;TRPM2;OPRM1;STIM2;CACNA2D4;TPCN2;TMCO1;CACNG4;PKD2L2;ANXA9;PKD2L1;PKD1L3;CACNA1B
prerank,gamma-tubulin binding (GO:0043015),0.4399481406649402,1.0890831287191125,0.34850863422291994,1.0,1.0,9/21,22.07%,RACGAP1;BRSK1;TUBGCP5;RAB11FIP5;B9D2;ARHGEF7;OFD1;TUBGCP6;BLOC1S2
prerank,cation channel activity (GO:0005261),0.34994998390668913,1.086213066876106,0.33908754623921084,1.0,1.0,18/94,14.45%,PIEZO2;OTOP1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;KCNK1;SLC4A11;PIEZO1;KCNK5;ANO10;AQP1;PKD1;TRPV2;KCNK10;KCNK4;TMEM63A
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.417511878556455,-1.084171213244451,0.36523929471032746,0.7757957865600492,1.0,6/13,20.04%,SLC7A1;SLC7A6;SLC15A4;SLC38A7;SLC38A5;SLC25A29
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3912110524131091,1.082162270428561,0.3540462427745665,1.0,1.0,15/37,23.87%,RARS2;TARS2;VARS1;CARS2;DARS1;KARS1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;TARS3;MARS2;PARS2
prerank,general transcription initiation factor binding (GO:0140296),-0.34903966032223455,-1.0815874862323587,0.3373134328358209,0.7759808313398964,1.0,10/25,28.84%,RUVBL1;AR;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11;THAP7
prerank,lysophospholipase activity (GO:0004622),-0.3693382029536435,-1.0806962764809165,0.37317784256559766,0.7718278377012807,1.0,5/20,14.11%,ENPP2;LYPLA1;ASPG;PNPLA6;LYPLAL1
prerank,semaphorin receptor activity (GO:0017154),-0.4350990185657792,-1.0805798230310295,0.3804347826086957,0.7652696713157576,1.0,2/11,1.37%,PLXNA2;PLXNA4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.435131780594317,1.0803719680229815,0.3672496025437202,1.0,1.0,4/21,6.68%,CDK15;CDKL3;CDK13;CDK7
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.435131780594317,1.0803719680229815,0.3672496025437202,1.0,1.0,4/21,6.68%,CDK15;CDKL3;CDK13;CDK7
prerank,protein tyrosine kinase binding (GO:1990782),0.35881324390935204,1.0799127630506467,0.35098522167487683,1.0,1.0,8/71,5.33%,LRP4;CEACAM1;SOCS5;CDH5;ITGAX;TJP2;PTPN14;BANK1
prerank,ion channel inhibitor activity (GO:0008200),0.39586824411184857,1.0790777180738138,0.3684971098265896,1.0,1.0,7/35,12.30%,NEDD4L;CAMK2D;STX1A;FKBP1B;VAMP8;NEDD4;ENSA
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.32572145065562563,-1.0783060079084825,0.3277027027027027,0.7645401370564655,1.0,9/34,14.92%,FAM20A;IGF2;CCNT2;CALM1;MAP2K2;CCNT1;RICTOR;CALM3;CDK5R1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4848691324917299,1.0774075892200732,0.39565943238731216,1.0,1.0,2/13,5.95%,RGS14;GDI1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.4988622899849539,1.0769978658039383,0.39273356401384085,1.0,1.0,1/11,0.64%,SGMS2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2638300577038117,-1.0734142741553347,0.3184713375796178,0.7710917942316159,1.0,25/100,12.04%,HIP1;PARD3;OSBPL8;ADAP2;MYO1B;CYTH3;COMMD1;SNX21;ZFYVE28;MYO10;ARAP3;DAPP1;KCNH1;HIP1R;SNX24;RPH3A;WIPI1;AKT1;FCHSD2;OSBPL5;IQGAP2;RUBCN;TECPR1;PLEKHF1;DENND1A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4654033058214665,1.0731566272165396,0.37925445705024313,1.0,1.0,9/15,20.74%,SOCS5;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;SOCS2;CISH
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.4639260320826759,1.0721063587621629,0.3781094527363184,1.0,1.0,3/15,7.04%,SLC4A3;SLC26A9;SLC4A11
prerank,death domain binding (GO:0070513),0.4995199150925544,1.0698410340721363,0.40625,1.0,1.0,3/11,8.84%,TRADD;MCL1;IRGM
prerank,myosin V binding (GO:0031489),-0.40055361411036217,-1.0684340111137298,0.3643031784841076,0.7788087953343247,1.0,6/15,22.09%,RAB6B;RAB3C;RAB11A;RAB3B;RAB11B;RAB10
prerank,protein homodimerization activity (GO:0042803),0.3026714739249252,1.0683669075702305,0.3005025125628141,1.0,1.0,127/589,17.74%,TENM2;ALDH1A3;F11R;INHBB;STC2;FGFR1;NR2F2;FOXP2;CEACAM1;CAMK2D;FAP;SLC8B1;AXIN1;PDLIM4;SLC39A13;GLCE;RDH5;TDG;MSH6;FXR2;KIF20B;NAGA;KMT2A;CAV2;TPD52;AADAT;ADD1;PHETA2;PAXX;S100A6;IRAK3;PIP4K2B;ATIC;TSG101;BHLHE40;CEP131;ADAM10;CLCN1;TMEM192;RABEP1;TRIM21;HOGA1;NRF1;TARS2;MCL1;NLRC4;MSH2;USF2;MAP3K5;DPP4;HSD17B4;S100B;DEFA6;COQ9;INPP5F;RPE;PDCD6IP;CASQ2;TBX18;PLEK;CUBN;ST6GAL1;PTPRT;CANT1;KARS1;ADRA2A;GSTZ1;GSTA4;TPR;RCHY1;KLHL7;CHMP4A;CHMP4B;MME;PAFAH1B2;GLDC;MZF1;XPNPEP3;EFEMP2;PRPS1;PRPS1L1;SNX2;CHMP4C;DGCR8;PGRMC1;CRPPA;MAP3K21;ABCD1;GEN1;PTPA;MYOM3;ABCB7;ATG7;STARD3;ERN1;SFPQ;AIMP1;FXR1;TXN;PTPRO;ERBB4;ABCB9;EXT1;FZD9;NECTIN3;TMEM266;ADCY8;TRIM5;MTMR1;TESC;SNX1;SCARB2;PRKRA;WARS1;BNIP3;CAMK2G;MAP3K9;CEP57;MIGA1;KYAT1;DCK;EXT2;ALS2;TERF2;DARS2;TYW5;LPL
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3300299377688073,-1.0671122515735225,0.3588235294117647,0.7755695361415798,1.0,13/28,28.15%,TNK2;RPS6KB1;MAP2K2;AKT1;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;RPS6KA1;MAP2K1;TTK;MAP2K4;MAP2K5
prerank,mRNA 3'-UTR binding (GO:0003730),0.3491685419779183,1.0636949220626093,0.37763975155279506,1.0,1.0,17/79,15.60%,HNRNPC;FXR2;DND1;CELF1;HNRNPA0;SECISBP2;PABPC4L;PABPC4;TUT1;IGF2BP2;ELAVL2;CELF2;ILF3;ZFP36L2;FXR1;PUM2;CPEB3
prerank,poly(U) RNA binding (GO:0008266),0.43442621693644173,1.0633549819548764,0.39384116693679094,1.0,1.0,4/20,7.87%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.3420830785937183,-1.0618376464418922,0.3592814371257485,0.7835366727742346,1.0,11/27,26.20%,MED21;POLR3B;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F;POLR2I
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4483222033480833,1.0562977313527466,0.3980263157894737,1.0,1.0,6/17,9.88%,ATP8B1;PITPNC1;PCTP;ATP8B2;ABCA1;ATP10B
prerank,pseudouridine synthase activity (GO:0009982),0.4755430046808705,1.0542367404777593,0.41008403361344536,1.0,1.0,3/13,6.98%,RPUSD2;PUS7;PUS3
prerank,pyridoxal phosphate binding (GO:0030170),-0.3667395854122593,-1.0537478833559228,0.3733681462140992,0.7998063134218781,1.0,13/20,35.47%,PDXK;CBS;PYGB;ACCS;AGXT;CTH;OAT;PNPO;PYGL;THNSL2;SHMT2;SHMT1;PYGM
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.392145723820345,1.0536099706152264,0.4106628242074928,1.0,1.0,11/34,10.07%,ARHGAP9;ARAP1;OGT;PHLDA3;RACGAP1;KIF16B;ZFYVE16;OBSCN;GAB2;MAPKAP1;FERMT2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.44589953509950464,-1.0534930489581922,0.38802660753880264,0.7938277571523765,1.0,3/10,2.73%,SLC24A3;SLC8A3;SLC8A1
prerank,ion channel activity (GO:0005216),0.3422843951836702,1.053309693897662,0.38,1.0,1.0,11/80,9.86%,PIEZO2;NALCN;TRPM3;GRIA3;TRPV4;TMC2;CNGB1;PIEZO1;GRID1;TMC4;GRIA1
prerank,chemorepellent activity (GO:0045499),-0.34077336229007754,-1.0527303705208453,0.35347432024169184,0.7892551998069731,1.0,5/25,5.19%,EPHA7;SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,phosphotyrosine residue binding (GO:0001784),-0.30828304337737955,-1.051163576219752,0.40273037542662116,0.7870444230207568,1.0,10/37,12.62%,PTPN3;PIK3R1;PIK3R3;SHE;PLCG2;CRK;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,potassium channel regulator activity (GO:0015459),0.3673949541646305,1.0480646179157935,0.4008207934336525,1.0,1.0,12/49,20.30%,NEDD4L;KCNIP4;KCNS3;KCNAB1;SGK1;SLC5A3;ENSA;YWHAE;CHP1;SUMO1;ADRB2;KCNIP1
prerank,protein phosphatase activator activity (GO:0072542),-0.40909799828432625,-1.0479477370230827,0.411214953271028,0.7895578615283968,1.0,8/13,32.61%,IGFBP3;CALM1;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,steroid hydroxylase activity (GO:0008395),0.4508069437490842,1.0464527562951595,0.37881219903691815,1.0,1.0,2/16,3.79%,CYP7B1;CYP2S1
prerank,WW domain binding (GO:0050699),-0.34397530852690955,-1.045477570920744,0.403954802259887,0.7895327998208554,1.0,3/26,4.00%,RAPGEF2;TNK2;LITAF
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4830070649211229,1.0452594020496169,0.4135593220338983,1.0,1.0,2/11,1.41%,ITPR2;ITPR3
prerank,endopeptidase activity (GO:0004175),0.30200496970227175,1.042504763452377,0.3968421052631579,1.0,1.0,50/257,17.26%,ADAMTS14;CORIN;MMP28;CTRC;ADAMTS12;ADAMTSL5;FAP;KLK2;ADAMTS1;PCSK5;ADAM19;MMP15;CD5L;ADAMTS19;USP8;ADAM10;ADAMTS2;DPP4;USP48;PSMB5;PCSK7;BACE2;USP47;USP13;MMP12;MME;PROC;CELA1;TASP1;KDM8;MMP16;ADAMTSL4;USP15;MIPEP;HTRA2;PSMB2;PSMA2;PSMA6;USP35;PLG;TYSND1;PSMA7;NLN;ZMPSTE24;ADAMTS20;BACE1;MBTPS1;MMP14;MASP2;USP37
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.35465176038876156,-1.0424031983427013,0.3994252873563218,0.7916346301706905,1.0,4/20,6.86%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,chemokine receptor activity (GO:0004950),0.41329592044473784,1.0415663434331852,0.40606060606060607,1.0,1.0,1/24,0.78%,ACKR3
prerank,kinase activity (GO:0016301),-0.24096484633169807,-1.041289399430872,0.34965034965034963,0.7882634318784667,1.0,26/109,14.92%,NADK2;CHKA;LYN;EPHA4;PDXK;CKB;PGM2L1;PAPSS1;ETNK1;AKT1;CAMK2A;PIK3C2A;DGKB;CDKL5;FCSK;PANK1;LRRK2;PMVK;CSNK2A1;IPMK;SPHK1;CDC7;DGKK;MVK;SEPHS1;CDK5R1
prerank,adrenergic receptor binding (GO:0031690),-0.37196041884053566,-1.04089486456008,0.41530054644808745,0.7831896224412822,1.0,2/16,1.05%,RAPGEF2;GNAS
prerank,phospholipase binding (GO:0043274),0.469579995844858,1.040635900224997,0.4075993091537133,1.0,1.0,6/13,20.41%,SRC;PAFAH1B1;SYK;BTK;PDPK1;PRKN
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.45939600855059703,1.040319569997258,0.40034364261168387,1.0,1.0,4/13,11.28%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,FMN binding (GO:0010181),0.47778124675875516,1.0387592693259757,0.4358047016274864,1.0,1.0,1/11,0.66%,POR
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3459638702895298,1.036925809531209,0.41312741312741313,1.0,1.0,16/69,15.84%,MOGAT2;CERS6;MOGAT3;AWAT2;KAT6B;PLAAT5;ZDHHC1;SOAT1;ZDHHC7;ZDHHC13;CREBBP;ZDHHC20;KAT8;ZDHHC8;NAA10;NMT1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.38960640008238856,-1.0355709297076159,0.423728813559322,0.7911012225126864,1.0,4/14,9.30%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,dipeptidyl-peptidase activity (GO:0008239),0.49242309451253047,1.032138799032617,0.42710120068610635,1.0,1.0,3/10,7.89%,FAP;NAALAD2;DPP4
prerank,lipid phosphatase activity (GO:0042577),0.44697241417558287,1.0310839268983745,0.4290484140233723,1.0,1.0,2/14,4.15%,PLPP2;PLPP3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.44021389932286953,1.0303897287381343,0.41471571906354515,1.0,1.0,4/15,11.28%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.261725587540093,-1.0267210741619506,0.4293785310734463,0.808954517797306,1.0,19/78,17.69%,CTSH;USP28;CAPN15;USP1;CTSL;USP42;USP20;CASP3;CFLAR;USP18;LGMN;USP33;CASP12;USP36;USP30;CASP6;CASP8;CTSC;CASP4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3826522956614832,1.0260953794550716,0.42796005706134094,1.0,1.0,18/33,26.43%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;ERBB2;SPTY2D1;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;HNRNPU
prerank,DNA binding (GO:0003677),0.28844985835182263,1.0259446467909452,0.4188376753507014,1.0,1.0,131/694,17.97%,RORA;MEOX2;NFATC2;GLI1;PPARGC1A;FOXD2;NR2F2;TSHZ3;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;PBX1;EGFR;MYBBP1A;ETV5;TDG;MSH6;NUFIP1;COLEC11;HIVEP2;GLI2;TFPT;CHD3;PCBP2;HLX;FOXO3;SOX9;PGR;WDR76;NPAS2;CHD8;HDAC4;CHD2;SATB1;NTHL1;BANF2;SMARCAD1;PDS5B;TSG101;GTF3C6;TAF4B;RFC3;ARID3A;STN1;NBN;ZDHHC1;C1D;SIRT3;CTCF;HIC1;PALB2;PAX3;TBX2;MSH2;MSL3;USF2;ILF2;RBM5;FOXK2;JRKL;ZBTB6;TET1;SLTM;MECP2;FOXJ1;HMGB1;ZMYM6;POU4F1;HDAC2;TRNP1;ERCC6;LONP1;MMP12;ILF3;SAP30L;RARG;EGR1;ERCC1;TDP1;ZBTB49;ZNF148;TOP1;ERF;MEN1;INO80;NFE2L2;MTERF2;POGK;CRLF3;CREBBP;ARID4A;NUCKS1;SFPQ;GTF3C5;MBD1;CBFB;RAD51AP2;POLG2;CAMTA2;REXO4;FOXF1;NR5A1;POU6F1;FAM111A;DEDD;AIFM2;POLE;FOXC2;KMT2D;DDB2;PBX4;SRRT;TSNAX;BATF;E2F1;QRICH1;ESRRA;HP1BP3;PPARG;RTF1;CUL4B;MTF2;TDP2;BRIP1;ORC1;CREM;RFC1;SYCP2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.4328608264673075,-1.0258107441340196,0.4409090909090909,0.8051313594908858,1.0,3/10,19.57%,SETD5;SMYD2;ASH1L
prerank,TBP-class protein binding (GO:0017025),-0.35012937533918215,-1.024973239115193,0.4396551724137931,0.8012072609387061,1.0,8/21,27.75%,RUVBL1;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11
prerank,GTPase activity (GO:0003924),0.30231643332948027,1.0236953960520276,0.42733188720173537,1.0,1.0,19/192,8.98%,GNA14;RAP1A;RAB8B;RAB29;MRAS;BMS1;GNAQ;MFN2;DNM1;RAC2;NRAS;KRAS;RHOJ;RAB3A;GNL2;ATL2;IRGM;GNG3;GNAL
prerank,solute:anion antiporter activity (GO:0140323),-0.38469756893088014,-1.0233935614657108,0.4306930693069307,0.7992897716871267,1.0,3/14,6.77%,SLC7A11;SLC26A7;SLC26A2
prerank,histone acetyltransferase activity (GO:0004402),0.3926113326238472,1.0205941583429798,0.43867243867243866,1.0,1.0,11/30,19.22%,HAT1;KAT6B;TAF10;NCOA3;CREBBP;KAT8;EPC2;TADA2A;MCM3AP;NAA40;NAA60
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.20008682324952587,-1.0187583060505236,0.3,0.804891669431922,1.0,119/431,21.53%,PRKAG2;DAPK1;KSR1;RHOBTB1;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;TGM2;CDC42;MTHFS;SNRK;TGFBR1;MFHAS1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;EEF1A1;BLM;MMAA;SMC4;TRNT1;HSPA8;TWF1;GBP3;HARS1;ABCC6;GBP4;MCM6;RHOC;ABCD4;GCH1;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;GTPBP10;RAB13;CDKL5;VPS4A;TUBB2A;RRAGC;RHOH;RHOB;TRIB1;MKNK1;GBP6;OXSR1;LRRK2;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PXK;SMARCA5;GBP7;SPHK1;MYO18A;SYN3;TUBB6;REM1;MTHFD1L;TUBB4B;ABCG1;RRAGD;MVK;SEPHS1;MTPAP;P2RX7;NOA1;HACL1;PEX6;GBP2;TUBB4A;P2RX4;EIF4G1;ARF5;ANXA6;NOL9;PEX1;RERG;ARL2;TSR1;DHX36;RHOT1;CLP1;RAB4A;DIRAS2;RAB11B;MYH9;KCNJ8;RHOF;PIM1;GNL3;TUBA1C;RAB32;DAPK3;PFKM;RAB2A;TUBA4A;DYNC1LI1;TUBB2B;SYN2;ARF3;RAB7A;RIT1;HRAS;PANK3
prerank,tau-protein kinase activity (GO:0050321),-0.3455075022277841,-1.0180468154783122,0.4462809917355372,0.8004916215478045,1.0,5/20,12.54%,ROCK2;MARK1;GSK3A;TTBK1;TAOK2
prerank,metallopeptidase activity (GO:0008237),0.31639727911056587,1.0177597954269837,0.43757431629013077,1.0,1.0,24/113,17.49%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;BRCC3;MMP15;ADAMTS19;RNPEP;ADAM10;ADAMTS2;LNPEP;MMP12;MME;MMP16;ADAMTSL4;MIPEP;COPS5;NLN;ZMPSTE24;ADAMTS20;MMP14;BMP1
prerank,actin binding (GO:0003779),0.3084971702802919,1.0164059518627653,0.45139664804469276,1.0,1.0,25/170,10.66%,UTRN;SORBS1;PARVA;PRKCE;COBL;CEACAM1;TLN2;PDLIM4;SPEF1;CAPZB;TRPV4;ADD1;PPP1R42;SHROOM2;ABL2;RDX;DAG1;TMOD1;MICAL3;CALD1;FLNB;CGN;FERMT2;GC;MTSS1
prerank,phospholipase activity (GO:0004620),0.3401388214301792,1.0147198684960699,0.4462915601023018,1.0,1.0,8/67,8.31%,PLCE1;PLCB3;DDHD1;GPLD1;PLCL1;PLAAT5;PLD3;ABHD12
prerank,sodium channel activity (GO:0005272),0.3675617606655179,1.0142764392273675,0.46153846153846156,1.0,1.0,5/37,7.04%,SCN10A;KCNK1;CACNA1H;SHROOM2;SLC4A11
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.45718077213667524,1.0124917676601215,0.4467005076142132,1.0,1.0,2/12,6.79%,OPN1MW;OPN1MW3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3634045317110261,-1.0112803857645267,0.46380697050938335,0.8121689053566649,1.0,5/17,9.11%,GRIA2;GRIN3A;GRIN2B;GRIK2;GRIN1
prerank,copper ion binding (GO:0005507),-0.2913016801329812,-1.0106963431077567,0.43223443223443225,0.8078204371091816,1.0,5/42,5.38%,MOXD1;ATP7A;COMMD1;LACC1;SOD3
prerank,palmitoyltransferase activity (GO:0016409),0.3914694710966701,1.008556293247279,0.45468277945619334,1.0,1.0,13/28,22.52%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.38829961733113955,1.0071133006061088,0.44294294294294295,1.0,1.0,9/25,10.01%,PHLDA3;SESTD1;KIF16B;PLEKHA4;OBSCN;TTPA;PLEK;GAB2;MAPKAP1
prerank,magnesium ion binding (GO:0000287),0.3122941075792987,1.0054703733496522,0.4531963470319635,1.0,1.0,41/135,20.42%,XYLT2;TDG;MSH6;STK38;IRAK3;THTPA;BRSK1;DXO;CERK;ABL2;NLRC4;STK38L;CLYBL;MSH2;MAP3K5;DIS3L2;PGM1;SRPK1;FOXK2;PLSCR1;STK3;SRPK2;NUDT18;GEN1;PRKACB;SIK3;ADPRS;ERN1;NT5C3A;RAN;PI4K2A;TESC;GEM;DYRK2;TDP2;PINK1;CDC42BPG;NME1;NUDT5;TKT;SIK2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4508990904079927,1.0036745866220818,0.45200698080279234,1.0,1.0,3/13,4.65%,CDH5;SRC;BMP5
prerank,RNA polymerase II complex binding (GO:0000993),0.37125276426198406,1.0030411576468667,0.45,1.0,1.0,16/32,26.43%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;HNRNPU
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.27138066007770717,-1.0004198976851109,0.468,0.8302977834726796,1.0,8/55,6.32%,SLC24A3;ITPR1;TRPC3;TRPC1;ANXA2;CACNB2;ORAI1;ATP2C1
prerank,neurexin family protein binding (GO:0042043),0.4706906520456995,1.0002639423252955,0.4780316344463972,1.0,1.0,2/10,4.70%,CEL;CPE
prerank,receptor tyrosine kinase binding (GO:0030971),0.3374193519289442,0.9994994100858862,0.4599483204134367,1.0,1.0,8/56,10.34%,LRP4;SOCS5;ITGAX;PTPN14;TRADD;PIK3R2;GAB2;CBLB
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3975992664287591,0.9993202105641864,0.4613050075872534,1.0,1.0,11/24,22.43%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,poly-pyrimidine tract binding (GO:0008187),0.39941546131359695,0.9992132500003515,0.45085803432137284,1.0,1.0,4/23,7.87%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.452642788736834,0.9989883963303099,0.44945848375451264,1.0,1.0,1/12,1.29%,SULF1
prerank,endopeptidase regulator activity (GO:0061135),0.3596109492513028,0.9989422981788674,0.4546742209631728,1.0,1.0,4/40,6.99%,SPINK1;APH1B;PSME3;NLRC4
prerank,ribonuclease P activity (GO:0004526),0.4617837570123652,0.9982199872123587,0.49012567324955114,1.0,1.0,6/11,24.93%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.36897776864766596,0.996497549144296,0.46628407460545196,1.0,1.0,3/38,4.90%,SERPINB2;SERPING1;SERPINH1
prerank,BMP receptor binding (GO:0070700),0.4509020027350852,0.9953956715685631,0.453125,1.0,1.0,3/12,4.65%,CDH5;SRC;BMP5
prerank,RNA stem-loop binding (GO:0035613),-0.4020557804379053,-0.995354777993819,0.48514851485148514,0.8383055566963997,1.0,5/12,18.07%,LARP6;MYH10;ZC3H12A;RC3H1;METTL16
prerank,carboxypeptidase activity (GO:0004180),0.3605892391258957,0.9950941813461031,0.4623044096728307,1.0,1.0,7/35,9.67%,NAALAD2;AGBL4;CPE;CPA2;SCPEP1;BLMH;MINDY2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3324994221247054,0.994542021308156,0.45353159851301117,1.0,1.0,3/73,3.10%,SORCS2;KISS1R;MC5R
prerank,UDP-galactosyltransferase activity (GO:0035250),0.46341491443866023,0.9920693596033205,0.46846846846846846,1.0,1.0,2/10,5.84%,B3GALT1;A3GALT2
prerank,GTPase regulator activity (GO:0030695),0.29138359081243975,0.9896576200636851,0.4795258620689655,1.0,1.0,20/212,6.44%,ARHGAP42;SIPA1L1;DLC1;RGS6;RGS14;ARHGAP31;ARHGAP18;ARHGAP32;GRTP1;ARHGAP9;ARAP1;DOCK1;SGSM2;NF1;OPHN1;RACGAP1;GNAQ;GDI1;ARHGAP26;RAB3GAP2
prerank,histone demethylase activity (GO:0032452),-0.3197541894550637,-0.9890100174553557,0.47440273037542663,0.8493431523975257,1.0,6/27,12.83%,KDM5C;PHF8;KDM2B;JARID2;KDM1A;KDM7A
prerank,sodium:proton antiporter activity (GO:0015385),-0.40202944312194655,-0.9882233704289245,0.47045454545454546,0.845528123597586,1.0,5/11,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,deubiquitinase activity (GO:0101005),0.31790290444685537,0.9876380357540919,0.47961630695443647,1.0,1.0,24/88,18.82%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;MINDY2;USP47;PAN2;USP13;OTUD7B;MINDY4;USP15;USP4;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.34640209485990564,0.9874963838281827,0.4709141274238227,1.0,1.0,12/49,11.27%,TNIP3;BRCC3;WDR81;TNFAIP3;UBL7;TNIP1;UIMC1;MINDY2;SHARPIN;OTUD7B;TAB2;HDAC6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3993560975178787,-0.9864558205066329,0.48201438848920863,0.8442678081240971,1.0,2/11,6.28%,KCNK2;KCNT1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.390107518167505,-0.9856442052848894,0.47555555555555556,0.8406505463660017,1.0,4/12,21.90%,DUSP10;DUSP3;DUSP7;DUSP1
prerank,proton transmembrane transporter activity (GO:0015078),0.35710226872049067,0.9848718615492128,0.4754335260115607,1.0,1.0,8/39,15.52%,OTOP1;COX5A;SLC4A11;COX15;NNT;COX5B;SLC46A1;CLCN5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28658660163760746,0.9845642575215635,0.5148305084745762,1.0,1.0,25/248,8.98%,GNA14;KIF2A;RAP1A;RAB8B;RAB29;MRAS;KIF20B;CHD3;BMS1;VWA8;GNAQ;MFN2;DNM1;RAC2;THTPA;NRAS;KRAS;KIF3C;RHOJ;RAB3A;GNL2;ATL2;IRGM;GNG3;GNAL
prerank,anion channel activity (GO:0005253),0.33264823847314795,0.9831741699362917,0.49193548387096775,1.0,1.0,9/61,12.26%,VDAC2;LRRC8D;SLC26A9;ANO6;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,protein kinase C activity (GO:0004697),0.4355515365770794,0.9823745808449801,0.4816666666666667,1.0,1.0,2/14,4.28%,PRKCE;PRKCA
prerank,chemokine binding (GO:0019956),0.37162564659938124,0.9823442508913883,0.48206599713055953,1.0,1.0,5/30,21.16%,ACKR3;HMGB1;CCR5;ITGB1;CX3CR1
prerank,methyl-CpG binding (GO:0008327),-0.32312157203786807,-0.98228844500526,0.4794520547945205,0.843835543205065,1.0,5/22,13.18%,ZBTB38;CXXC5;WDR77;ZBTB21;LRWD1
prerank,ribonuclease P RNA binding (GO:0033204),0.4630268263423058,0.9815211666732796,0.48613678373382624,1.0,1.0,5/10,23.14%,POP4;POP7;RPP14;RPP21;RPP30
prerank,anion:anion antiporter activity (GO:0015301),0.41754559366273725,0.9807905825716582,0.492845786963434,1.0,1.0,2/17,2.36%,SLC4A3;SLC26A9
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.36422535049616944,0.9789001714413792,0.49420289855072463,1.0,1.0,18/33,26.43%,ZNF326;RPRD1B;LLPH;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;TBP;HNRNPU
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2926379611912344,0.9768455168594661,0.5310796074154853,1.0,1.0,52/188,21.85%,BNC2;GLI1;PBX1;ZBTB20;ETV5;CHD3;SPI1;FOXK1;FOXO3;GLIS2;HDAC4;CREB3L1;CTCF;NCOR1;LIN54;SUV39H1;FOXK2;TBX18;FOXJ1;HMGB1;TFEB;EGR1;MZF1;MEN1;NFE2L2;ARID4A;SOX4;SFPQ;ERBB4;FOXC2;YAP1;KMT2D;PER3;DMTF1;PSPC1;TFE3;MTERF3;PPARG;SUV39H2;GABPA;XRCC6;DHX9;CREB3L2;DDIT3;TAF2;ASH2L;PAX2;RUNX1;ZBED4;FOXC1;TCF7L2;JUN
prerank,ribosomal small subunit binding (GO:0043024),-0.34095261487271,-0.9730167300992906,0.4758454106280193,0.8625063767882467,1.0,9/17,28.27%,NPM1;CPEB2;MTIF2;ABCE1;PIM1;EIF1B;DHX29;ERAL1;DDX3X
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.44875421806313054,0.9729075762423808,0.48545454545454547,1.0,1.0,6/10,28.38%,GLCE;RPE;DSE;GNE;DSEL;RENBP
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.296021721367007,-0.9724529375597217,0.5,0.8580427828308118,1.0,7/33,10.31%,RNF217;RNF125;ARIH1;TRAF6;RNF144B;UBA2;RPS3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.30691782570649023,-0.9706294284483711,0.5057803468208093,0.8568527607158882,1.0,5/27,7.26%,RNF217;RNF125;ARIH1;TRAF6;RNF144B
prerank,low-density lipoprotein particle binding (GO:0030169),0.41318484722698184,0.9691761260429301,0.500823723228995,1.0,1.0,1/16,0.50%,CDH13
prerank,cytokine activity (GO:0005125),0.2992334482038482,0.967814624844365,0.5056433408577878,1.0,1.0,9/131,5.38%,INHBB;IL19;WNT10A;WNT2B;IL1A;WNT16;BMP5;WNT5A;BMP15
prerank,hyaluronic acid binding (GO:0005540),-0.4103902373247159,-0.9677371927252145,0.48491879350348027,0.8588470866477563,1.0,4/10,25.90%,LAYN;C1QBP;LYVE1;CHODL
prerank,"DNA binding, bending (GO:0008301)",0.42462641054640315,0.965114958318152,0.4660033167495854,1.0,1.0,3/14,11.05%,FOXD1;HMGB1;SAP30L
prerank,chemokine receptor binding (GO:0042379),-0.28450017725440974,-0.964585488979442,0.5266666666666666,0.861296865064357,1.0,25/35,52.22%,CXCL16;CXCL12;CCL13;CCL19;CCL2;CXCL10;CCL25;CCL28;CCRL2;CCL5;CXCL5;CCL11;CCL15;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,histone deacetylase activity (GO:0004407),0.39635800979343255,0.9630663418478458,0.5062305295950156,1.0,1.0,5/19,11.27%,HDAC4;SIRT3;SIRT7;HDAC2;HDAC6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.45153278164996047,0.9629144229830873,0.48312611012433393,1.0,1.0,3/11,10.61%,AKR1B10;RDH14;RDH13
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.38588937116582334,-0.9606828186049757,0.5038167938931297,0.8655419602045167,1.0,6/12,17.46%,CDK12;CDK9;CDK6;CDK8;CDK4;CDK19
prerank,protein serine/threonine kinase activity (GO:0004674),0.27632650636249173,0.9578981024033121,0.6022964509394572,1.0,1.0,43/335,9.79%,PLK2;FAM20C;CDK15;PRKCE;CAMK2D;EGFR;MINK1;CLK1;STK38;MAP3K1;CASK;MAPK10;EIF2AK3;BMPR1B;PRKCA;CDKL3;LIMK2;IRAK3;ACVR1C;TRIO;HIPK1;PIK3R4;BRSK1;NEK7;CDK13;BCKDK;CDK7;BMP2K;CLK4;STK38L;MAPK7;MAP3K5;SRPK1;DYRK1A;NRBP2;KALRN;CSNK1G3;STK24;STK3;GSK3B;RPS6KA3;MASTL;CSNK1A1
prerank,adenylate cyclase binding (GO:0008179),0.44537285265551985,0.9578789263586142,0.478584729981378,1.0,1.0,2/10,5.35%,AKAP12;ADCY5
prerank,amino acid:sodium symporter activity (GO:0005283),0.4400582045563919,0.9575446267017982,0.5293040293040293,1.0,1.0,2/11,5.55%,SLC38A2;SLC6A13
prerank,hormone receptor binding (GO:0051427),0.42023430447446447,0.9568304494873444,0.5174708818635607,1.0,1.0,6/14,26.36%,PTHLH;TYK2;JAK1;SOCS2;ADCYAP1;CCK
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2048246941903634,-0.9557974916643265,0.6666666666666666,0.8731354759341842,1.0,60/254,16.39%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;RBX1;TRIOBP;HIF1A;BECN1;SPOP;TNFRSF1B;HSPA8;GABARAPL1;DNAJA1;ARIH1;TRAF6;UBE2N;NEDD8;DBT;SLF2;UBE2K;ACTG1;BCL10;ATP6V0C;NAE1;VCP;GPR37;GABARAP;SLF1;SLC22A18;TRIM28;UBE2J1;TPI1;TRIB1;RPL23;ANKRA2;RNF31;AMBRA1;CUL2;RAD18;BAG4;PRKAR2B;HERC2;ERLIN2;YWHAZ;NKD2;FZD8;ISG15;RNF8;TRIM37;LAPTM5;SMC6;CBS
prerank,cytochrome-c oxidase activity (GO:0004129),0.4117248751724294,0.9540508911653834,0.5092748735244519,1.0,1.0,3/15,13.18%,COX5A;COX15;COX5B
prerank,sequence-specific mRNA binding (GO:1990825),-0.394212945680537,-0.9519050807421835,0.5290023201856149,0.8770277192492919,1.0,5/10,28.00%,SSB;LARP6;DHFR;SHFL;RBM24
prerank,microtubule motor activity (GO:0003777),0.33319335849698056,0.9516819047455065,0.5198412698412699,1.0,1.0,10/51,13.61%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF26A;KIF5A;KIF5B
prerank,chloride transmembrane transporter activity (GO:0015108),-0.35191936188370554,-0.9497124638011714,0.5469879518072289,0.8767136393960452,1.0,4/16,13.71%,SLC26A7;SLC26A2;SLC12A5;SLC1A1
prerank,tubulin binding (GO:0015631),0.27460569051036876,0.949204992547113,0.5944272445820433,1.0,1.0,63/295,17.35%,DLEC1;RGS14;GTSE1;HOOK2;KIF2A;SPEF1;KIF20B;TTLL1;TRPV4;RACGAP1;FAM83D;AGBL4;DNM1;SMC3;KIF16B;CAPN6;BRSK1;KIF7;PPP1R42;IFT81;SPAST;KIF3C;DAG1;CKAP5;SGIP1;KIF13A;PAFAH1B1;EML1;FNTA;REEP3;IFT74;TUBGCP5;TPR;S100A9;APC;HDAC6;HOOK3;MAP4;CCDC170;RAB11FIP5;NDE1;MAP9;INO80;ARL8B;KIF26A;KIF5A;MAPRE2;EMD;KIF5B;HTT;POLB;FAM161A;CRIPT;TBCE;EZR;B9D2;SYBU;ARHGEF7;TTLL9;AGBL1;CEP57;CHP1;SETD2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.38902313871524075,-0.9478656773701591,0.5454545454545454,0.8757790880973846,1.0,2/10,8.57%,PIK3R3;PIK3C2A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.37708539882435677,0.9477520318757195,0.5311526479750779,1.0,1.0,6/23,10.01%,PHLDA3;SESTD1;KIF16B;SH3PXD2B;PLEKHA4;MAPKAP1
prerank,protein kinase C binding (GO:0005080),-0.2684283986843064,-0.9460547446858584,0.5302013422818792,0.8745856415064034,1.0,19/43,24.20%,GRK5;PARD6G;SQSTM1;HDAC7;HDAC9;ADCY4;PDLIM5;DACT2;HSPB1;HINT1;RACK1;PICK1;CAVIN3;NELL1;TOP2B;TOP2A;ADCY6;PRKCB;DSP
prerank,protein kinase binding (GO:0019901),0.2679937261076883,0.9452520037845787,0.6384692849949648,1.0,1.0,62/479,11.32%,ROR2;CAV1;TRIB2;UTRN;CSPG4;CEACAM1;CNKSR2;SLC12A2;CCND3;FAM83A;KCNA5;GYS1;NELL2;AXIN1;PARD6B;CDH5;STK38;MAP3K1;SPRED1;TRPV4;TJP2;CAV2;RACGAP1;PRKAG1;FOXO3;SOX9;SLC12A4;FAM83D;HNRNPA0;DNM1;RAC2;IRAK3;DACT1;PTPRC;IBTK;BANK1;TOM1L1;ANKRD2;ADAM10;TRIM21;SRCIN1;MSH2;MAPK7;RARA;FBXO5;PRKAR2A;PTPRJ;TNIP1;TEX14;IRGM;PLEK;GSK3B;TOM1L2;TICAM1;MAPKAP1;FERMT2;LAT;ADRA2A;TPR;APC;PRKCSH;SPAG9
prerank,snoRNA binding (GO:0030515),0.3629380877220466,0.9446687880936144,0.53125,1.0,1.0,6/30,12.72%,NUFIP1;BMS1;NOP14;SNU13;NOP56;NOP58
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.4358597011479878,0.9434633848948166,0.5189456342668863,1.0,1.0,1/11,1.41%,ITPR3
prerank,exoribonuclease activity (GO:0004532),0.4289308501044667,0.943352513148864,0.5307167235494881,1.0,1.0,3/12,9.99%,EXOSC5;EXOSC10;CNOT7
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3775316184081402,-0.9426595921254192,0.5200945626477541,0.8779995904052791,1.0,5/12,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.29079205672214337,-0.9417330871041438,0.5507692307692308,0.8749906354857917,1.0,2/29,1.72%,PRKAG2;PKIG
prerank,protein phosphatase 2A binding (GO:0051721),-0.31739784115114056,-0.9416056808728899,0.5376344086021505,0.869711284649613,1.0,7/23,14.31%,MFHAS1;FOXO1;CTTNBP2NL;GRIN3A;IGBP1;SPHK1;MAPT
prerank,ribonuclease activity (GO:0004540),0.32602010056305575,0.9409240000063442,0.562082777036048,1.0,1.0,16/56,23.67%,PIWIL2;EXOSC5;N4BP1;DIS3L2;AGO1;EXOSC10;CNOT7;EXOG;ERN1;DICER1;TSNAX;RNASE3;EXOSC7;SMG6;RNASE1;RNASEH1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.44012489753508305,0.9408489927673115,0.5369127516778524,1.0,1.0,5/10,19.22%,HAT1;MSL3;KAT8;NAA40;NAA60
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3054143395537767,0.9403388227991999,0.5513447432762836,1.0,1.0,22/83,18.82%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;USP47;PAN2;USP13;OTUD7B;USP15;USP4;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,calcium ion binding (GO:0005509),0.2680116096788445,0.937710633835774,0.6322314049586777,1.0,1.0,29/323,9.06%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;ITPR3;CDH11;SLC25A12;GLCE;CDH5;ACER3;KCNIP4;COLEC11;CDH17;CDH9;TPD52;S100A6;NUCB1;CALR3;S100A7A;ANXA4;LTBP4;RCN1;CDH2;S100B;EML1;PLSCR1;CASQ2;CD320
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.27786598800649764,0.9376305383857209,0.5597826086956522,1.0,1.0,30/181,14.89%,MDFIC;PPARGC1A;NFATC1;LDB2;SPI1;HDAC4;DACT1;BHLHE40;TAF4B;ANKRD2;ANXA4;NRIP1;TEAD3;NCOR1;PIAS2;ISL1;DDRGK1;GSK3B;PTPRT;HDAC2;NCOR2;FAF1;NCOA3;NFE2L2;CREBBP;NCOA2;TCERG1;BAZ2A;PSMA6;WWP2
prerank,phosphatidylinositol binding (GO:0035091),0.2959484183255794,0.9358883264484552,0.5683709869203329,1.0,1.0,7/91,6.96%,PIGU;ITPR2;ITPR3;PITPNC1;SESTD1;ZFYVE16;SNX10
prerank,miRNA binding (GO:0035198),0.3546369811609832,0.9355501910148235,0.5414847161572053,1.0,1.0,13/30,25.77%,DND1;RBM10;ZNF346;AGO1;PUM2;SPOUT1;PUM1;ELAVL1;ZC3H7B;DDX21;FMR1;PNPT1;AGO2
prerank,voltage-gated cation channel activity (GO:0022843),-0.2243950353900424,-0.9341801142660048,0.6265060240963856,0.8826987349558236,1.0,37/97,35.01%,CACNA2D3;KCNB1;KCNMA1;GRIN3A;CACNB2;GRIN2B;KCNH1;KCNB2;KCNH5;GRIN1;CACNG7;KCNC3;CACHD1;OPRM1;CACNA2D4;TPCN2;KCNA2;KCND1;LRRC38;CACNG4;CACNA1B;KCNH2;KCNH8;HCN2;CACNA1D;KCNQ5;HVCN1;KCNQ1;LRRC55;KCNC4;CACNA2D1;CACNA1C;KCNG2;CACNB3;KCNH4;HCN4;CACNG5
prerank,metallocarboxypeptidase activity (GO:0004181),-0.29989298651261326,-0.9331280147678199,0.5403726708074534,0.8799864158348921,1.0,8/26,18.40%,AEBP1;FOLH1;AGBL5;CPXM2;CPD;CPA6;ACE2;VASH1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.43084179236465325,0.9310413185662116,0.5536028119507909,1.0,1.0,2/11,5.22%,SLC22A3;SLC25A20
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3468896216393379,0.9303775109384346,0.5442857142857143,1.0,1.0,7/34,16.02%,UBE2L6;UBE2E2;UBE2I;UBE2J2;UBE2D3;UBE2D1;UBE2R2
prerank,glycerophospholipid flippase activity (GO:0140333),0.4260616146823504,0.9301940943149749,0.5468483816013628,1.0,1.0,4/11,9.88%,ATP8B1;ATP11C;ATP8B2;ATP10B
prerank,E-box binding (GO:0070888),-0.2763318798996184,-0.9270893887396128,0.5555555555555556,0.8896649348652269,1.0,2/34,3.98%,TCF4;MITF
prerank,heme binding (GO:0020037),0.30454125744994925,0.9236766718003901,0.5689001264222503,1.0,1.0,9/65,13.28%,STC2;PXDN;CYP2S1;SRC;COX15;SDHD;DGCR8;PGRMC1;CYP2U1
prerank,cyclic nucleotide binding (GO:0030551),-0.31554764942920455,-0.9232596192243723,0.5680628272251309,0.8934720047985498,1.0,6/21,12.95%,RAPGEF2;PDE5A;KCNH1;PDE10A;PDE2A;PDE4A
prerank,neuropeptide receptor binding (GO:0071855),0.4185205851565889,0.9225169085430928,0.5557432432432432,1.0,1.0,5/14,28.13%,APLN;AGRP;PPY;SHANK1;NPY
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3529225168529844,0.9223226022653628,0.5476550680786687,1.0,1.0,6/27,11.18%,SLC8B1;SLC12A3;KCNK1;SLC4A11;SLC9A7;SLC9A6
prerank,filamin binding (GO:0031005),0.4259291384587594,0.9195790386389127,0.5511265164644714,1.0,1.0,1/11,1.25%,CEACAM1
prerank,nuclear export signal receptor activity (GO:0005049),0.42294013430634353,0.9181868885844112,0.5396825396825397,1.0,1.0,6/11,26.07%,CSE1L;RAN;XPO5;XPO4;XPO7;RANBP17
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27550782091092135,-0.9173617098467648,0.5760517799352751,0.9019782214205302,1.0,8/35,18.12%,POU2F1;FOXP1;NPM1;HDAC1;DRAP1;TBPL1;DR1;TAF1C
prerank,bHLH transcription factor binding (GO:0043425),-0.329453797130816,-0.9172950332009399,0.5988372093023255,0.8965254760729996,1.0,5/19,12.56%,SMAD3;LMO2;MAP3K10;KDM1A;SP1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.26241406723467664,-0.9148785884785687,0.6231884057971014,0.8972272781096475,1.0,10/42,12.62%,PTPN3;PIK3R1;PIK3R3;SHE;PLCG2;CRK;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,Notch binding (GO:0005112),-0.302725398521673,-0.9146578893619248,0.5887323943661972,0.8923420625711876,1.0,6/22,9.65%,SNED1;CCN3;GALNT11;JAG2;KCTD10;SNW1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.19222392050029227,-0.9085314279811647,0.8070175438596491,0.9017154269855062,1.0,60/269,16.39%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;RBX1;TRIOBP;HIF1A;BECN1;SPOP;TNFRSF1B;HSPA8;GABARAPL1;DNAJA1;ARIH1;TRAF6;UBE2N;NEDD8;DBT;SLF2;UBE2K;ACTG1;BCL10;ATP6V0C;NAE1;VCP;GPR37;GABARAP;SLF1;SLC22A18;TRIM28;UBE2J1;TPI1;TRIB1;RPL23;ANKRA2;RNF31;AMBRA1;CUL2;RAD18;BAG4;PRKAR2B;HERC2;ERLIN2;YWHAZ;NKD2;FZD8;ISG15;RNF8;TRIM37;LAPTM5;SMC6;CBS
prerank,metal ion binding (GO:0046872),0.257547352466568,0.9085225719030757,0.7449392712550608,1.0,1.0,52/477,9.22%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;ITPR3;CDH11;SLC25A12;XYLT2;GLCE;CDH5;ACER3;TDG;MSH6;KCNIP4;COLEC11;CDH17;STK38;CDH9;TPD52;HMGCLL1;S100A6;NUCB1;IRAK3;THTPA;ACVR1C;CALR3;BRSK1;DXO;S100A7A;ANXA4;CERK;ABL2;LTBP4;NLRC4;STK38L;CLYBL;MSH2;MAP3K5;RCN1;CDH2;DIS3L2;PGM1;SRPK1;S100B;EML1;FOXK2;RPE;PLSCR1;CASQ2;CD320;STK3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.41958344633816064,0.9069402404493695,0.568695652173913,1.0,1.0,2/12,9.70%,CYFIP2;EIF4E
prerank,mitogen-activated protein kinase binding (GO:0051019),0.34028317264191427,0.9064366385823249,0.5611620795107034,1.0,1.0,6/29,13.05%,NFATC1;MAPK7;PTPRJ;TNIP1;TPR;DUSP8
prerank,omega peptidase activity (GO:0008242),0.2907300931424276,0.9052720721533989,0.6162227602905569,1.0,1.0,23/89,18.82%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;USP47;PAN2;USP13;OTUD7B;USP15;USP4;USP35;COPS5;GGT1;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,phospholipid transfer activity (GO:0120014),-0.3052942765567851,-0.9048612941377847,0.5994397759103641,0.9050636233299969,1.0,6/21,14.16%,PLTP;PITPNB;TNFAIP8L3;C2CD2L;PRELID2;PRELID3A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.37939383635910323,-0.90471140566378,0.6057906458797327,0.9001470802068328,1.0,5/10,34.17%,CACNB2;CACNA1B;CACNA1D;CACNA1C;CACNB3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.372503019000871,-0.904235755926678,0.5674418604651162,0.8958476671603157,1.0,5/10,26.19%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D;DNAJC2
prerank,kinase inhibitor activity (GO:0019210),0.3355716393831401,0.9030590647869724,0.5735512630014858,1.0,1.0,12/33,22.31%,PARVA;SPRY4;GMFB;MAPK8IP1;HEXIM1;CDKN1C;SOCS1;WARS1;NCK1;GSKIP;YWHAB;TAOK3
prerank,growth factor receptor binding (GO:0070851),0.28550032004638953,0.9008862300906517,0.6157517899761337,1.0,1.0,19/95,17.10%,FGF7;EFEMP1;GLMN;FGF1;SRC;FER;NCSTN;PTPRJ;FGF18;PLSCR1;ATXN2;IL6ST;SNX2;ERN1;HBEGF;ERBB4;PIBF1;SNX1;ITGA5
prerank,calcium activated cation channel activity (GO:0005227),-0.3148873893328238,-0.9007672176188983,0.5703125,0.8987254751200802,1.0,4/17,10.43%,ANO1;KCNMA1;TMEM63B;KCNN2
prerank,poly(A) binding (GO:0008143),-0.306099161439863,-0.9006225934181679,0.5927835051546392,0.8938359019697997,1.0,5/21,9.68%,RBPMS;RBMS1;RBMS3;RBMS2;PABPC1
prerank,RNA binding (GO:0003723),0.2520040482672505,0.8996278115308015,0.861,1.0,1.0,347/1321,22.78%,AHNAK;DCN;DHX34;DHX8;PPARGC1A;RPSA;HNRNPC;ASS1;MYBBP1A;CCDC9;CSTF1;CDC42EP4;NUFIP1;FXR2;RBFOX2;HOXB6;DDX27;DND1;QKI;SF3B2;SF3B1;CHD3;BMS1;GIGYF2;PCBP2;RBM8A;DCP1B;SCG3;ADD1;MRPL37;RBM10;MRPL43;UBE2I;CELF1;SRSF4;BUD23;HNRNPA0;NOL8;SECISBP2;PABPC4L;DNM1;CHD2;SAMD4B;SERPINH1;RPUSD2;CAVIN1;SNRPF;HADHB;RBM15B;ZNF326;SON;PABPC4;LRRC59;DXO;ZNF346;HNRNPR;TLR7;CDK13;PUS7;TNS1;KPNA2;TUT1;ZC3H15;FASTKD2;SF3B5;C1D;EIF5B;PPIE;MRPS28;MRPS35;ZCCHC24;N4BP1;LLPH;RARS2;RDX;PRPF3;UTP15;NCOA5;FAM120A;ZFR;ARHGEF1;ALDH18A1;DDX17;CSTF3;CHERP;GNL2;TOP3B;MSI2;DDX46;NOP14;RBM22;ILF2;GOLGB1;SRPK1;RBM5;IGF2BP2;ELAVL2;GPATCH8;SIDT2;DARS1;PCDHGA9;NAF1;RPL35;AATF;WRAP53;AGO1;TCF20;DCAF13;LIN28B;PTCD3;SNU13;SLTM;MRPL41;FLNB;MECP2;CELF2;STAU2;HMGB1;PES1;POP4;EXOSC10;EIF4E;FCF1;CELF4;RPS13;HDAC2;RBM33;RBM27;HNRNPM;PRRC2A;EIF1AX;EIF1;TFB2M;KARS1;RRP12;PTBP3;MRPS15;DQX1;PPHLN1;RBM26;KHDRBS2;ZYX;TPR;POP7;RTRAF;LONP1;DDX43;SRPK2;ATXN2;ILF3;DBR1;MRPL3;LUC7L2;UPF3B;RPF1;UTP14A;CFAP20;HEXIM1;SREK1;TOP1;MAP4;ETF1;SRRM2;ANXA11;DGCR8;CSDE1;UBAP2L;ADAT1;NOP56;PTBP2;RPP14;STRBP;RBM18;LTA4H;NOP58;TEP1;KNOP1;SMG7;TAF15;NSUN5;ZFP36L2;DDX6;NUCKS1;TCERG1;SNRPA1;SFPQ;ALKBH1;NOL7;AIMP1;BAZ2A;NSRP1;MEX3A;TEFM;P4HB;PPIG;FXR1;UBA1;DDX42;CHCHD1;TIAL1;DDX52;RTN4;BZW1;TXN;PUM2;FASTKD1;PPIL4;PYM1;PSMA6;MRPL16;DICER1;REXO4;RBM38;CTNNA1;DHX16;PDCD11;TRA2B;SF1;BICC1;SUGP1;RAN;SEC23IP;CPEB3;ATP5F1A;FLYWCH2;ATP5F1C;DHX57;YWHAG;ZCCHC17;SPOUT1;SRRT;TSNAX;EZR;PSPC1;MRPL40;MRPL22;THOC5;PRKRA;MRM1;YWHAE;DHX40;SYNCRIP;GNL3L;CWC22;RTF1;XPO5;GLRX3;UBFD1;HMGN2;MRPL4;SPTBN1;DARS2;TYW5;ARCN1;ZCCHC7;NOC3L;PTCD1;SARS2;OAS2;NAP1L1;GTPBP1;MRPL2;SRFBP1;STRAP;RPUSD4;PNLDC1;SRSF3;ZNFX1;PEG10;SRBD1;CNOT1;TOE1;G3BP1;HARS2;LSM3;XRCC6;MTREX;GCN1;DHX38;PNISR;DHX9;YBX3;DDX56;SEPSECS;HNRNPD;SUMO1;MBNL2;LARP4;NCBP3;RPP21;NME1;NUDT5;TRMT1L;SAP18;EIF4G2;CS;ZC3H13;JAKMIP1;MKRN1;NUDT21;CCT3;TDRD9;RRS1;GFM1;SRSF12;NKAP;USO1;KCTD12;ADARB1;SRSF11;TIA1;HABP4;TSFM;MRPS7;LRRC47;CCAR2;ZBED4;ENO1;EXOSC7;SRSF10;DDX11;PUM1;SRP68;HSPA9;SECISBP2L;ELAVL1;JUN;FNDC3B;DDX25;YTHDC1;NMD3;THG1L;TFB1M;TRMT1;MRPL11;HELB;SMG6;HNRNPA3;GANAB;PKM;NOL12;PCF11;LSM2;JMJD6;ZC3H18;CPSF2;RBM6
prerank,chloride channel regulator activity (GO:0017081),0.3943536620575101,0.8984763411868141,0.6,1.0,1.0,4/14,18.61%,STX1A;VAMP8;SGK1;CHRNA7
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3878418436994187,0.8982633309091028,0.5732899022801303,1.0,1.0,3/16,12.31%,SLC29A4;SLC22A3;SLC25A26
prerank,DNA secondary structure binding (GO:0000217),0.3366702165051541,0.8977185747137199,0.6011730205278593,1.0,1.0,7/31,12.90%,MSH6;KMT2A;LIN54;MSH2;HMGB1;MEN1;GEN1
prerank,phospholipase activator activity (GO:0016004),0.42767769343450546,0.8975797210199551,0.5614334470989761,1.0,1.0,4/10,18.55%,SRC;BTK;STX4;PDPK1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.35095139623632765,-0.8969082469066334,0.5785714285714286,0.8974327208040451,1.0,5/13,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,ankyrin binding (GO:0030506),0.3656701752421511,0.8957265667482246,0.5932203389830508,1.0,1.0,6/19,20.19%,PTPRC;OBSCN;FLNC;CDH1;SPTBN1;SPTB
prerank,lipoprotein particle binding (GO:0071813),0.36849404349294196,0.8945352011102523,0.5977564102564102,1.0,1.0,1/20,0.50%,CDH13
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3912896117911049,0.8941069480599644,0.6079734219269103,1.0,1.0,5/14,13.00%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,CCR chemokine receptor binding (GO:0048020),-0.2829168300901124,-0.890615945987452,0.627906976744186,0.9066386561344425,1.0,20/28,52.13%,NES;CCL13;CCL19;CCR2;CCL2;CCL25;CCRL2;CCL5;CCL11;CCL15;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.36816398686922325,-0.8892550915659102,0.5981524249422633,0.9045086428469165,1.0,5/11,23.69%,NUDT3;NUDT11;DCP2;NUDT16;NUDT16L1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2815731430747722,-0.8889676105260591,0.6350148367952523,0.8999551227533917,1.0,7/26,22.90%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;STYXL1;PTN;ARPP19
prerank,carboxylic acid binding (GO:0031406),-0.2673049074749294,-0.8887964406801594,0.6773049645390071,0.8952161939244824,1.0,11/38,20.40%,UBR1;NOS3;GRIN3A;GRIN2B;GRIN1;GLRA2;MAG;NOS1;GCLC;CASTOR2;CASTOR1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3086455293513872,0.887803108873379,0.6083333333333333,1.0,1.0,10/52,15.23%,PPARGC1A;SLC30A9;PSMC3IP;MED13;TMF1;NCOA3;NCOA2;BRD8;CCDC62;MED12
prerank,FAD binding (GO:0071949),0.3510570824563062,0.8850254706027125,0.5987654320987654,1.0,1.0,1/24,0.45%,PRODH
prerank,epidermal growth factor receptor binding (GO:0005154),0.34594698073893715,0.8843623813434448,0.6181277860326895,1.0,1.0,8/25,16.43%,EFEMP1;FER;PLSCR1;ATXN2;SNX2;HBEGF;ERBB4;SNX1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.35441006803932995,0.8833246797986614,0.5972006220839814,1.0,1.0,6/22,11.08%,WDR81;TNFAIP3;UIMC1;MINDY2;OTUD7B;TAB2
prerank,mRNA binding (GO:0003729),0.2599238908568135,0.8830849532127248,0.7228144989339019,1.0,1.0,44/249,15.02%,HNRNPC;FXR2;RBFOX2;DND1;QKI;SF3B1;PCBP2;RBM8A;DCP1B;CELF1;SRSF4;HNRNPA0;SECISBP2;PABPC4L;SAMD4B;PABPC4;DXO;HNRNPR;TUT1;PPIE;N4BP1;CSTF3;RBM5;IGF2BP2;ELAVL2;RPL35;CELF2;CELF4;RPS13;HNRNPM;PTBP3;KHDRBS2;TPR;LUC7L2;UPF3B;ETF1;SRRM2;PTBP2;DDX6;NSRP1;FXR1;PUM2;TRA2B;SF1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3773203301539827,0.8822809121701672,0.5989932885906041,1.0,1.0,2/16,5.83%,ALOXE3;BCO1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.38747230626851914,0.8811990129394269,0.5814332247557004,1.0,1.0,1/14,1.84%,KCNA5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.26976379012569696,0.8795490076833569,0.6819221967963387,1.0,1.0,22/134,11.57%,SLC35A1;SLC4A3;SLC25A12;SLC35D3;SFXN2;SLC26A9;SLC38A2;SLC1A7;SLC35B2;SLC27A1;SLC22A3;ABCC1;SLC6A13;SLC2A2;SLC4A11;SLC52A1;SLC35D2;SLC7A2;RTBDN;SLC16A1;SLC25A13;SLC3A1
prerank,kinesin binding (GO:0019894),0.3365433033513281,0.8794886833692145,0.6006006006006006,1.0,1.0,13/27,25.44%,RAB29;FAM83D;MAPK8IP1;SPAG9;ARHGEF10;KLC2;PRC1;SPTBN5;CLSTN1;MAPK8IP3;NEK6;TTBK2;KIFAP3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.38954125376793153,0.8775459232790332,0.5930807248764415,1.0,1.0,6/12,18.95%,CNOT7;PAN2;CNOT8;PNLDC1;CNOT1;TOE1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35908457788058956,-0.8759396779325278,0.6295454545454545,0.9194117522216418,1.0,2/11,10.16%,CXCL12;YARS1
prerank,iron ion binding (GO:0005506),-0.24067921946896373,-0.8731019879979893,0.7003891050583657,0.9202136364275879,1.0,12/48,15.19%,EGLN1;PHF8;FTH1;FTL;AOX1;ETHE1;NFU1;FECH;ABCE1;KDM7A;FXN;ISCA2
prerank,phosphatase inhibitor activity (GO:0019212),0.34968612661035314,0.8720199787557421,0.6146496815286624,1.0,1.0,8/20,25.39%,STYX;BOD1L1;ENSA;TESC;LMTK2;PPP1R9B;URI1;PPME1
prerank,potassium ion antiporter activity (GO:0022821),-0.3304531327610877,-0.871952117690843,0.6275510204081632,0.917668424629114,1.0,5/15,18.66%,SLC24A3;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,mannosyltransferase activity (GO:0000030),-0.29475665702445986,-0.8705965656723408,0.6576819407008087,0.9157250987944514,1.0,3/21,4.35%,TMTC2;TMTC1;DPM1
prerank,MHC protein binding (GO:0042287),0.36140575487669657,0.8698819501314776,0.6339563862928349,1.0,1.0,5/20,16.11%,TAPBP;CD81;ABCB9;ATP5F1A;LAG3
prerank,GABA receptor activity (GO:0016917),0.35394726735893584,0.8692804954804665,0.6009463722397477,1.0,1.0,5/21,12.26%,GABBR2;GABRR2;GABRG2;GABRG1;GABRB3
prerank,potassium channel activity (GO:0005267),-0.21027581209783897,-0.8690118892449372,0.7637362637362637,0.9141673547306987,1.0,10/89,10.43%,KCNK2;KCNB1;ABCC9;KCNMA1;KCNH1;KCNT1;GRIK2;KCNB2;KCNH5;KCNN2
prerank,methyltransferase activity (GO:0008168),0.30884585582700735,0.8689919651657422,0.6348547717842323,1.0,1.0,9/46,13.64%,MRM2;BUD23;SUV39H1;LRTOMT;GAMT;FTSJ1;ARMT1;MGMT;LCMT1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.34519446469726167,-0.8687273620996514,0.6491228070175439,0.9097177947818312,1.0,4/12,20.15%,PHF8;KDM1A;KDM7A;KDM4D
prerank,microtubule binding (GO:0008017),0.2559885303137312,0.8672522643754687,0.7315789473684211,1.0,1.0,38/222,14.15%,RGS14;GTSE1;HOOK2;KIF2A;SPEF1;KIF20B;TRPV4;RACGAP1;FAM83D;DNM1;KIF16B;CAPN6;KIF7;SPAST;KIF3C;CKAP5;SGIP1;KIF13A;PAFAH1B1;EML1;FNTA;REEP3;TUBGCP5;S100A9;APC;HDAC6;HOOK3;MAP4;CCDC170;NDE1;CEP290;MAP9;KIF26A;KIF5A;MAPRE2;KIF5B;POLB;FAM161A
prerank,MAP kinase activity (GO:0004707),-0.3305003363716125,-0.8665371075885763,0.6388206388206388,0.9093443091118817,1.0,2/14,6.93%,MAPK4;MAPK12
prerank,single-stranded telomeric DNA binding (GO:0043047),0.40574891877879904,0.8640926330651381,0.5989672977624785,1.0,1.0,6/11,28.07%,STN1;TERF2;RAD50;RPA2;RPA1;TERF2IP
prerank,carboxy-lyase activity (GO:0016831),0.34705296708513755,0.863853924484576,0.6382978723404256,1.0,1.0,3/23,8.59%,PISD;AZIN2;ACOD1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3776851640831891,0.8632982011216194,0.5940099833610649,1.0,1.0,1/14,1.39%,AK5
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3659385459761877,-0.8631787175523437,0.662870159453303,0.9114761175682891,1.0,4/10,24.90%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D
prerank,ligand-gated cation channel activity (GO:0099094),0.28451753537624935,0.8615686607587317,0.6599496221662469,1.0,1.0,6/75,6.15%,KCNJ4;KCNJ16;GRIA3;KCNK1;KCNJ13;SHROOM2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.32432712182865453,-0.8613251739130515,0.6414141414141414,0.9102362616125496,1.0,6/14,27.94%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,protein phosphatase regulator activity (GO:0019888),-0.23435671668262123,-0.8608087903534419,0.7442748091603053,0.9064350070734222,1.0,20/53,29.85%,PPP2R2B;PPP4R4;CALM1;IGBP1;PPP4R1;CALM3;PPP2R5A;RCAN2;PPP2R5E;STYXL1;PPP4R2;PTN;PPP2R1A;ARPP19;PPP2R5D;DMPK;PPP2R2D;SHOC2;PPP1R16B;PPP1R15A
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2508967658673223,-0.8590846792667418,0.7446043165467626,0.905282359543289,1.0,15/37,35.01%,CACNA2D3;CACNB2;CACNA1G;CACNG7;CACHD1;OPRM1;CACNA2D4;TPCN2;CACNG4;CACNA1B;CACNA1D;CACNA2D1;CACNA1C;CACNB3;CACNG5
prerank,chloride channel inhibitor activity (GO:0019869),0.40249124767997796,0.8582196784884403,0.638733705772812,1.0,1.0,2/10,11.35%,STX1A;VAMP8
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2840094477679664,0.8581417218417946,0.6683046683046683,1.0,1.0,15/74,15.62%,FAM20C;DGKA;HK2;DGKZ;COASY;ADPGK;GALK1;IDNK;GALK2;GK;HYKK;PIK3C3;NT5C3A;PANK2;FGGY
prerank,methylation-dependent protein binding (GO:0140034),0.29405155752890766,0.8561496452151363,0.6649810366624526,1.0,1.0,24/57,28.33%,MSH6;CHD8;CHD1;MORC3;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;BPTF;KDM5A;ING1;TDRD3;RRP8;GLYR1;KDM4A;ING3;ING2
prerank,voltage-gated potassium channel activity (GO:0005249),0.27539853143371523,0.8554853432293338,0.68,1.0,1.0,6/80,5.58%,KCNJ4;KCNA5;KCNJ16;KCNS2;KCNK1;KCNJ13
prerank,ubiquitin binding (GO:0043130),0.2783615933393504,0.8538286400024397,0.6877370417193426,1.0,1.0,14/73,13.44%,UBE2L6;NUP62;TOM1L1;TSG101;TNFAIP3;OTUB2;N4BP1;NPLOC4;SHARPIN;USP13;NEDD4;BUB3;FAF1;RNF185
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34083030927932706,0.8513436502619399,0.6599378881987578,1.0,1.0,8/24,23.52%,AK5;PPIP5K2;PPIP5K1;AK7;ITPKA;NME1;AK9;NME6
prerank,four-way junction DNA binding (GO:0000400),0.36090663123306516,0.850394234243257,0.6704730831973899,1.0,1.0,5/17,12.90%,MSH6;MSH2;HMGB1;MEN1;GEN1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.31708339599455804,0.8465589356689134,0.644793152639087,1.0,1.0,6/31,16.02%,UBE2L6;UBE2E2;UBE2J2;UBE2D3;UBE2D1;UBE2R2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.31222965418553283,-0.8461533350658299,0.6776649746192893,0.9273367868091743,1.0,5/15,12.53%,NDST3;HS3ST1;HS3ST3B1;HS6ST2;HS6ST1
prerank,phosphatidic acid binding (GO:0070300),0.353988083555279,0.8428832838914803,0.6534810126582279,1.0,1.0,6/19,10.01%,PITPNC1;SESTD1;GRAMD1B;PACSIN2;RAPGEF6;MAPKAP1
prerank,R-SMAD binding (GO:0070412),-0.3076134615980403,-0.8386242242347702,0.6908602150537635,0.9373951367756425,1.0,2/18,1.65%,SMAD3;SMAD6
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2874958757888203,0.8384066224325126,0.6975228161668839,1.0,1.0,20/60,19.36%,PPM1A;CTDSPL;PPM1M;RPAP2;PHLPP1;MTMR6;MTMR3;PDP2;CTDSP1;PTEN;CTDSP2;PPP4C;CTDSPL2;CDC14A;CAMK2G;PPP1CA;PP2D1;PPTC7;ILKAP;PPP2CA
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3392158882029924,-0.8383182297597715,0.6599496221662469,0.9330627044313844,1.0,4/11,30.79%,KCNJ8;KCNE4;KCNH2;KCNQ1
prerank,vitamin D receptor binding (GO:0042809),-0.31727307580479946,-0.8371825452987617,0.674937965260546,0.9305698733373274,1.0,7/14,31.09%,MED17;SNW1;MED24;MED14;MED30;TAF11;RXRA
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2727367767481276,-0.8349142467276381,0.7182741116751269,0.9299565493581716,1.0,5/22,16.71%,ATP6V0A4;ATP2C1;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,ADP binding (GO:0043531),0.3237895853161844,0.8345851496465067,0.6533127889060092,1.0,1.0,10/25,16.57%,MSH6;PRKAG1;COQ8A;MSH2;MIEF1;LONP1;ABCD1;ERN1;ATP5F1A;PGK1
prerank,cation transmembrane transporter activity (GO:0008324),0.29518261955370845,0.834428830968888,0.6868965517241379,1.0,1.0,5/48,4.89%,SLC8B1;SFXN2;SLC38A2;SLC29A4;SLC22A3
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.30656730333905097,0.8342037143075826,0.6731571627260083,1.0,1.0,10/34,18.95%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;PNLDC1;CNOT1;TOE1
prerank,CoA hydrolase activity (GO:0016289),0.3581135587258289,0.8334525228083334,0.6321070234113713,1.0,1.0,4/16,12.75%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24523077774899743,0.8324735686555402,0.7815482502651113,1.0,1.0,28/232,11.37%,NEDD4L;PDZRN3;ZNRF2;DTX1;PELI2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;PIAS2;SIAH1;ZNRF3;CUL3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;RCHY1;ANAPC11;NEDD4
prerank,thyroid hormone receptor binding (GO:0046966),0.3126911288380834,0.8324676274328472,0.6816816816816816,1.0,1.0,9/28,21.22%,NCOR1;MED13;JMJD1C;NCOA3;GTF2H1;BRD8;MED12;TACC1;MED16
prerank,N-acetyltransferase activity (GO:0008080),-0.29318396826411414,-0.8310575854419407,0.689119170984456,0.9324455728626303,1.0,8/19,30.45%,EP300;SMARCE1;SAT1;KAT2B;NAT8L;NAT2;NAT10;NAA50
prerank,poly-purine tract binding (GO:0070717),-0.2679837330141864,-0.8307406776840508,0.7369942196531792,0.9282449677128739,1.0,5/27,9.68%,RBPMS;RBMS1;RBMS3;RBMS2;PABPC1
prerank,fibroblast growth factor binding (GO:0017134),0.3386299103102236,0.8285068197053604,0.6666666666666666,1.0,1.0,1/21,0.70%,FGFR1
prerank,metalloexopeptidase activity (GO:0008235),0.2865047961116326,0.8271023687096949,0.7192513368983957,1.0,1.0,13/51,16.99%,MMP15;AGBL4;CPE;CPA2;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;ZMPSTE24;MMP14;AGBL1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.28405657458851974,0.825607988464518,0.6907630522088354,1.0,1.0,5/53,8.51%,PRODH;POR;GFER;GCDH;MICAL3
prerank,amino acid binding (GO:0016597),-0.257104448887412,-0.8238769587440019,0.7586206896551724,0.936704896415799,1.0,11/31,20.40%,NOS3;DDAH1;GRIN3A;GRIN2B;GRIN1;GLRA2;NOS1;GCLC;AGXT;CASTOR2;CASTOR1
prerank,RNA cap binding (GO:0000339),0.35558032984503113,0.8238008164812166,0.6452145214521452,1.0,1.0,2/16,9.70%,CYFIP2;EIF4E
prerank,voltage-gated sodium channel activity (GO:0005248),0.3287927442791849,0.8222175051047714,0.6885245901639344,1.0,1.0,3/22,11.00%,SCN10A;CACNA1H;SCN2B
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.30457260880736947,-0.8217214806818905,0.756544502617801,0.9361792650981,1.0,8/16,21.17%,SLC13A3;SLC25A30;SLC25A11;SLC38A7;SLC1A1;SLC25A18;SLC1A4;SLC13A5
prerank,galactosyltransferase activity (GO:0008378),0.37693418309326554,0.8215547677255907,0.6414762741652021,1.0,1.0,2/11,5.84%,A4GALT;A3GALT2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.32310535035324367,-0.8207707352713931,0.7167070217917676,0.9333060649087379,1.0,3/12,16.15%,TRAF6;BABAM2;TRIM37
prerank,phospholipase inhibitor activity (GO:0004859),-0.34448856240017844,-0.8177893504210237,0.7060085836909872,0.9342729817895126,1.0,7/10,36.98%,ANXA2;ANXA1;ANXA9;ANXA5;APOC1;SNCA;SNCB
prerank,ribosomal large subunit binding (GO:0043023),-0.3288409418042718,-0.817787479594099,0.6757990867579908,0.9295836622536243,1.0,3/11,12.34%,NPM1;CPEB2;DHX33
prerank,NF-kappaB binding (GO:0051059),-0.261880376855523,-0.8163241997335016,0.7546666666666667,0.9274345906285011,1.0,10/24,23.54%,EP300;RNF25;NPM1;HDAC1;BCL10;COMMD7;MTDH;CDK5RAP3;BRMS1;SETD6
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.31730282060643733,0.8160258658311487,0.6962209302325582,1.0,1.0,5/29,13.33%,PGGHG;ACER3;NEU1;ABHD10;ADPRS
prerank,single-stranded DNA binding (GO:0003697),-0.2023075923384222,-0.8140291754663923,0.8789473684210526,0.9271211657710655,1.0,39/93,32.05%,RAD51B;SAMHD1;TOP3A;RBMS1;BLM;MCM6;SUB1;PCBP1;SPRTN;SSBP1;POLA1;PMS2;MAPT;APTX;RAD23A;SMC6;DHX36;POLR2D;MCMDC2;ERCC4;CRY2;ERCC5;TWNK;HNRNPA1;NEIL3;WBP11;RAD51;NABP1;CDC45;FUBP1;HMCES;MCM3;CTC1;MCM9;MCM7;HSPD1;MCM5;MCM10;MCM2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.34661378082080585,0.8139039899646652,0.6842948717948718,1.0,1.0,2/18,9.42%,TNFAIP8;RPS6KA3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.30470053113780476,-0.8132630219427353,0.7333333333333333,0.9238745429429698,1.0,12/14,41.98%,QDPR;MTHFR;DHFR;ALDH4A1;PYCR2;AASS;PYCR3;BLVRB;PYCR1;NOXRED1;CRYM;ALDH1L1
prerank,titin binding (GO:0031432),0.3509519696146138,0.8131489163325226,0.6875,1.0,1.0,2/13,8.79%,CAMK2D;OBSCN
prerank,G protein-coupled receptor activity (GO:0004930),0.2381379317781795,0.8116931251005399,0.8192389006342494,1.0,1.0,23/239,12.71%,HRH1;LPAR1;ADGRG5;ADGRG2;GPR161;SSTR1;KISS1R;MC5R;MRGPRF;P2RY14;OPN1MW;OPN1MW3;GABBR2;GPR135;TSHR;HCRTR2;GPR101;RORB;ADRA2A;GPR183;LANCL1;GRM1;GPR18
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.20851289545036752,-0.8112617293057234,0.861904761904762,0.9226132084547563,1.0,11/70,14.97%,GXYLT2;MGAT4C;MGAT4A;CSGALNACT1;CSGALNACT2;CHPF2;B4GALT1;B3GALT2;LFNG;GCNT1;MFNG
prerank,nucleosomal DNA binding (GO:0031492),0.32681585969562554,0.8111803810480288,0.6929260450160771,1.0,1.0,3/21,9.90%,HNRNPC;SMARCD2;HDAC2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2775527353141015,0.8109095109337272,0.723489932885906,1.0,1.0,11/57,15.68%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,phosphatase activity (GO:0016791),0.2636342837678484,0.809899710475114,0.7739463601532567,1.0,1.0,14/73,15.11%,DUSP12;PLPP2;ACP6;PLPP3;PTPN22;ACP5;ATP1A2;PTPMT1;PTPRJ;OCRL;ARMT1;DUSP8;PTPRO;PLPPR1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.23240043201913327,-0.8088106407105798,0.8246268656716418,0.9221718827466401,1.0,27/42,38.29%,CCNT2;CNPPD1;CCNT1;CDK5R1;CCNE2;CCNH;CCNJL;KAT2B;CCNY;CCND2;CCNF;CDKN2C;CDKN1B;CCNQ;CCNK;CDKN2D;CCND1;CCNB2;HEXIM2;CCNL1;CDKN2B;CCNL2;CKS2;CDK5R2;CCNI;CCNE1;INCA1
prerank,thioesterase binding (GO:0031996),0.3686836444116622,0.8080308131008079,0.6809605488850772,1.0,1.0,7/11,23.34%,ARF6;ADRA2A;TRAF4;TRAF3;TRAF5;HAUS7;RAC1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3044627177847184,0.8066055337895878,0.7332361516034985,1.0,1.0,9/34,18.17%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3044627177847184,0.8066055337895878,0.7332361516034985,1.0,1.0,9/34,18.17%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2
prerank,ubiquitin protein ligase activity (GO:0061630),0.23782123020678506,0.8060552579174592,0.842720510095643,1.0,1.0,27/228,11.37%,NEDD4L;PDZRN3;ZNRF2;DTX1;PELI2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;SIAH1;ZNRF3;CUL3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;RCHY1;ANAPC11;NEDD4
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.36336921915187304,0.8054262714441374,0.6834782608695652,1.0,1.0,4/13,16.38%,SOX9;PRKAR2A;GSK3B;EZR
prerank,cAMP binding (GO:0030552),-0.3311172633561724,-0.8037282768348085,0.7341176470588235,0.926899994159758,1.0,4/11,12.95%,RAPGEF2;PDE10A;PDE2A;PDE4A
prerank,GABA-A receptor activity (GO:0004890),0.33753996389429397,0.803588775843557,0.6731707317073171,1.0,1.0,4/18,12.26%,GABRR2;GABRG2;GABRG1;GABRB3
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3382044077199111,0.8035382142967173,0.6940418679549114,1.0,1.0,4/17,12.75%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.32956214047021026,-0.8019397789947469,0.7220956719817767,0.9254557215990998,1.0,4/11,14.11%,RBX1;UBE2K;UBE4A;UBE4B
prerank,nuclear import signal receptor activity (GO:0061608),0.34133088071812256,0.8012928509957006,0.6916802610114192,1.0,1.0,2/15,5.83%,KPNA7;KPNA2
prerank,small GTPase binding (GO:0031267),0.2415954890551004,0.8008472287666513,0.821826280623608,1.0,1.0,40/170,19.35%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;GCC1;AKAP13;LZTR1;RAPGEF4;RAB3GAP2;RAPGEF6;OCRL;ABCA1;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;DMXL2;RANBP2;EXOC5;EVI5;TRIP11;PDE6D;RAB34;UNC13B;CHM;AP3M1;TBC1D20;RTKN;XPO5;ARHGDIB;RALBP1;ALS2;SIKE1;EHD1;DENND10;ANKFY1;RAF1;YBX3
prerank,1-phosphatidylinositol binding (GO:0005545),0.34237047990096847,0.7973845787413241,0.7217675941080196,1.0,1.0,3/15,6.96%,SESTD1;ZFYVE16;SNX10
prerank,methylated histone binding (GO:0035064),0.26989217093508977,0.7961408025306933,0.7506265664160401,1.0,1.0,25/62,28.33%,MSH6;CHD8;CHD1;MORC3;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;BPTF;KDM5A;TAF1;ING1;TDRD3;RRP8;GLYR1;KDM4A;ING3;ING2
prerank,protein heterodimerization activity (GO:0046982),0.23926316669210873,0.7951242847984922,0.8274725274725274,1.0,1.0,31/178,17.31%,TENM2;NPAS3;FXR2;ADD1;BUD23;SMC3;IRAK3;ATP1A2;BHLHE40;MCL1;GABBR2;USF2;PAFAH1B1;PIK3R2;SUPT4H1;ADRA2A;ZHX1;HEXA;PAFAH1B2;SNX2;P4HB;FXR1;EXT1;FZD9;RAN;ADCY8;ERBB2;SNX1;YWHAE;MIGA1;EXT2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3633805935614882,0.7950866367863937,0.6987740805604203,1.0,1.0,1/12,2.58%,CDH5
prerank,cAMP response element binding (GO:0035497),-0.33562284031674433,-0.7945218137859547,0.7206572769953051,0.9333591004926644,1.0,3/10,11.60%,CREB5;CREB1;ATF2
prerank,potassium ion leak channel activity (GO:0022841),0.3418638944105326,0.7932124130100423,0.7032786885245902,1.0,1.0,4/15,13.89%,KCNK1;KCNK5;KCNK10;KCNK4
prerank,single-stranded RNA binding (GO:0003727),0.28512240658540194,0.7914269097255056,0.7393103448275862,1.0,1.0,18/43,26.43%,TLR7;ZFR;AGO1;EXOSC10;LONP1;ILF3;STRBP;FXR1;DHX9;DDX11;JMJD6;IFIH1;DHX58;AQR;FMR1;AGO2;CNBP;HNRNPU
prerank,triglyceride lipase activity (GO:0004806),0.33590810245478153,0.7911465498427637,0.7069243156199678,1.0,1.0,3/20,17.74%,CEL;LIPE;LPL
prerank,kinase binding (GO:0019900),0.22569591899974192,0.7909635187310915,0.9219858156028369,1.0,1.0,49/434,10.37%,CAV1;UTRN;CSPG4;CEACAM1;CNKSR2;SLC12A2;EGFR;CCND3;FAM83A;KCNA5;GYS1;AXIN1;STX1A;MAP3K1;SPRED1;TRPV4;CAV2;RACGAP1;PRKAG1;FOXO3;SLC12A4;PTPN22;FAM83D;HNRNPA0;SRC;DNM1;RAC2;IRAK3;PTPRC;IBTK;TOM1L1;TRADD;ADAM10;TRIM21;SRCIN1;MSH2;FBXO5;PTPRJ;TEX14;IRGM;GSK3B;TOM1L2;TICAM1;DLG3;MAPKAP1;FERMT2;LAT;TAX1BP1;ADRA2A
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.34945429653161125,0.7907750235027228,0.7190635451505016,1.0,1.0,6/13,30.37%,GEN1;DICER1;SLX4;DNASE1L1;ENDOV;DNA2
prerank,RNA methyltransferase activity (GO:0008173),-0.2769403320042202,-0.7898203600801034,0.8291316526610645,0.9364232568907335,1.0,8/19,24.75%,TGS1;TRMT13;TRMT9B;TRDMT1;FBL;TYW3;METTL8;TRMT12
prerank,semaphorin receptor binding (GO:0030215),-0.26250141391006976,-0.7894882894913119,0.8005698005698005,0.9325681642911747,1.0,4/23,5.19%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,transcription cis-regulatory region binding (GO:0000976),0.22613516209837758,0.789393397325027,0.9143730886850153,1.0,1.0,62/406,17.11%,RORA;BNC2;GLI1;PBX1;ZBTB20;NPAS3;ETV5;CHD3;SPI1;FOXK1;FOXO3;SOX9;ZBTB8A;GLIS2;HDAC4;SATB1;KLF10;CREB3L1;ZFP3;SP3;ZFP90;CTCF;NCOR1;HOXC10;RREB1;RARA;SUV39H1;LHX6;ISL1;E4F1;FOXK2;AGO1;TBX18;FOXJ1;HMGB1;DBP;TFEB;LONP1;MMP12;EGR1;MZF1;MEN1;NFE2L2;PEG3;ARID4A;SOX4;SFPQ;ZFP57;ERBB4;FOXF1;NR5A1;FOXC2;YAP1;KMT2D;GBX1;PER3;DMTF1;PSPC1;TFE3;MTERF3;E2F1;PPARG
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.23589248450764233,0.7890539471324696,0.836824696802646,1.0,1.0,27/173,13.87%,FOXP2;ZBTB32;KLF12;ZBTB20;FOXK1;FOXO3;FOXP4;SATB1;CREB3L1;HEYL;BHLHE40;ZFP90;CTCF;HIC1;TBX2;MYPOP;E4F1;FOXK2;ZBTB6;TBX18;MZF1;ZBTB49;ZNF148;ERF;PEG3;NFATC4;ZFP57
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3173691976254442,-0.788331717419112,0.7153284671532847,0.9301986210446042,1.0,3/11,17.76%,SLC17A5;SLC2A10;SLC2A9
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.2791948402542376,-0.7829920990034381,0.7788697788697788,0.930153323388376,1.0,4/16,16.71%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.2791948402542376,-0.7829920990034381,0.7788697788697788,0.930153323388376,1.0,4/16,16.71%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3458019986617025,0.7825046478006009,0.7223140495867768,1.0,1.0,4/14,20.49%,CAPN6;CAPN2;CAPN5;CAPN1
prerank,cholesterol transfer activity (GO:0120020),0.3364351939802048,0.7822570539328432,0.7169811320754716,1.0,1.0,7/16,26.12%,GRAMD1B;ABCA1;STARD5;OSBPL2;STARD4;MTTP;NPC2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.28938486108111267,0.7809905685697491,0.7559607293127629,1.0,1.0,9/33,18.95%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;PNLDC1;TOE1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.32166061994061435,0.7801680311962397,0.7435897435897436,1.0,1.0,8/19,22.54%,GRID1;GABRG2;GABRG1;GRIK1;GRIK5;GABRA3;GRIK3;GRID2
prerank,sulfotransferase activity (GO:0008146),0.29404183386381216,0.7796805315743547,0.7424892703862661,1.0,1.0,5/33,11.13%,UST;SULT1A1;CHST7;CHST2;CHST12
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.28185983278316856,0.7794997696708318,0.7453505007153076,1.0,1.0,8/38,11.71%,PHLDA3;SESTD1;LANCL2;KIF16B;SH3PXD2B;PLEKHA4;OBSCN;ZFYVE26
prerank,transferrin receptor binding (GO:1990459),0.3629110394670626,0.7792373459083434,0.7246891651865008,1.0,1.0,4/10,21.30%,SNX2;CD81;SNX1;RGMA
prerank,MAP kinase kinase activity (GO:0004708),-0.29268604196997733,-0.7781495676595965,0.7896103896103897,0.9331193475889424,1.0,8/15,28.15%,MAP2K2;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;MAP2K1;MAP2K4;MAP2K5
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.21883416731757047,-0.7749207469972768,0.8698630136986302,0.9340764363248594,1.0,5/44,8.59%,MECOM;SETD5;SETD1A;PRDM16;SMYD2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.29131587185999924,0.7749156043200816,0.7799174690508941,1.0,1.0,14/32,24.96%,EGLN3;TET1;P4HTM;KDM8;ALKBH1;PHYH;KDM4B;HSPBAP1;TYW5;ALKBH4;ALKBH2;KDM2A;TMLHE;ALKBH3
prerank,adenylyltransferase activity (GO:0070566),0.31747914962184026,0.7746121095690098,0.7361769352290679,1.0,1.0,6/21,18.56%,TUT1;COASY;NMNAT3;KARS1;OAS2;PAPOLG
prerank,solute:sodium symporter activity (GO:0015370),-0.2418855980795505,-0.7713636893572409,0.8192771084337349,0.9348509223700996,1.0,2/27,4.87%,SLC4A10;SLC5A6
prerank,NADPH binding (GO:0070402),-0.3033146654312021,-0.7701533574645237,0.7645631067961165,0.9322925438564375,1.0,7/13,34.09%,QDPR;DHFR;MTRR;CRYZ;DUS2;LBR;NDOR1
prerank,nucleotidyltransferase activity (GO:0016779),-0.2624821577993809,-0.7695386724576974,0.804945054945055,0.929003547964949,1.0,6/19,19.73%,PAPSS1;TENT2;TUT7;MTPAP;YRDC;CGAS
prerank,potassium:proton antiporter activity (GO:0015386),-0.3230119147736832,-0.769095906679707,0.7528344671201814,0.9254021079896787,1.0,4/10,18.66%,SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,lysine-acetylated histone binding (GO:0070577),0.31601106475636787,0.7688737457855925,0.7429906542056075,1.0,1.0,5/20,17.55%,MLLT3;KMT2A;BAZ2A;BRD3;PSME4
prerank,acetylation-dependent protein binding (GO:0140033),0.31601106475636787,0.7688737457855925,0.7429906542056075,1.0,1.0,5/20,17.55%,MLLT3;KMT2A;BAZ2A;BRD3;PSME4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.26086160277170045,0.7687808773883356,0.7736842105263158,1.0,1.0,9/54,11.27%,ACER3;HDAC4;NIT2;NADSYN1;NIT1;DARS1;SIRT7;HDAC2;HDAC6
prerank,phosphatidate phosphatase activity (GO:0008195),0.34148495067673923,0.7677087363381316,0.7546218487394958,1.0,1.0,2/13,4.15%,PLPP2;PLPP3
prerank,MHC class II protein complex binding (GO:0023026),0.3492914592240594,0.7672378933099583,0.7362068965517241,1.0,1.0,5/11,22.50%,ANXA11;CD81;YWHAE;MS4A1;PKM
prerank,N-acyltransferase activity (GO:0016410),0.2852915615964978,0.7667657520403761,0.7510980966325037,1.0,1.0,7/32,15.84%,CERS6;PLAAT5;SAT2;SIRT7;NAT14;NAA10;NMT1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3487347150037056,0.7664275677378781,0.7383015597920277,0.9994141067555757,1.0,4/12,18.56%,TUT1;TENT5C;TENT5D;PAPOLG
prerank,water transmembrane transporter activity (GO:0005372),0.35263867599832766,0.7650324902359734,0.7256944444444444,0.9987200059190477,1.0,2/11,12.99%,SLC4A11;AQP1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.30456394613149035,-0.7644170944515971,0.7957244655581948,0.9280477603843638,1.0,2/12,3.84%,PIK3R1;FRS2
prerank,tRNA binding (GO:0000049),-0.21987499178806538,-0.762420149171331,0.90234375,0.9267800475704521,1.0,21/43,39.52%,SSB;EEF1A1;TRNT1;TRMT9B;EIF2AK4;EIF2A;NSUN2;MRPS27;YRDC;XPOT;PUS1;HSD17B10;NAT10;AARS2;ELP1;FARS2;TRMT10C;CTU1;YARS2;NEMF;ELP5
prerank,lipase activity (GO:0016298),0.2746396872099266,0.7619626910997528,0.7591036414565826,1.0,1.0,9/43,19.50%,CEL;DDHD1;ABHD12;LIPE;PNPLA8;SEC23IP;LPL;PITPNM3;FAAH
prerank,motor activity (GO:0003774),0.26047211335415116,0.7613064170022726,0.8103225806451613,0.9986210468390897,1.0,10/60,13.61%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF26A;KIF5A;KIF5B
prerank,SH3 domain binding (GO:0017124),0.2574506788601021,0.761271288078979,0.8194805194805195,0.9957898687788487,1.0,16/62,21.23%,WIPF1;PTPN22;CNTNAP1;SGIP1;PLSCR1;CBLB;SH3BP2;SOCS7;LANCL1;RUFY2;REPS1;ESPN;PTPN12;AFAP1;PRKN;RAD9A
prerank,endoribonuclease activity (GO:0004521),0.28484840983994975,0.7604908748048759,0.7972972972972973,0.994192709968245,1.0,6/32,16.32%,PIWIL2;AGO1;EXOG;ERN1;DICER1;TSNAX
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3554123448294856,0.760094811577877,0.7431693989071039,0.9919183232001001,1.0,3/11,13.83%,NTHL1;APEX2;ALKBH1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.22098767546718162,0.7595724693577154,0.9361483007209063,0.9898587573320131,1.0,79/346,22.14%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;DTX1;PELI2;UBE2E2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LMO7;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;RNF24;SIAH1;ZNRF3;CUL3;FBXO3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;SHARPIN;OBI1;RCHY1;ANAPC11;NEDD4;KLHL21;FBXL5;TTC3;FBXO11;RFWD3;RNF185;FBXO21;ANKRD39;UBE2J2;UBE2D3;UBE2D1;ANAPC4;WWP2;FBXW8;TRIM5;DDB2;FANCL;UBE2R2;LTN1;FBXL3;ITCH;CUL4B;RNF7;VPS11;CDC23;RNF180;RNFT2;GID4;SEL1L;UBE2W;PRKN;MKRN1;RNF146;RNF14;MUL1;TRAF3;TRAF5;TRAF7;ZNRF1;AKTIP;RNF157;CUL5;MIB2;FBXW11
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.25540067815566786,-0.7573258432873924,0.8494623655913979,0.9294402533721944,1.0,13/21,50.77%,GRIK2;P2RX7;P2RX4;CHRNA4;CHRNB2;P2RX5;CHRNB1;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.34724635626797873,0.7572818448818412,0.7389078498293515,0.990510989544557,1.0,5/11,25.76%,FBXO11;PRMT6;PRMT9;PRMT8;PRMT3
prerank,acetyltransferase activity (GO:0016407),0.2863269495891785,0.756477678302672,0.7717231222385862,0.989071792049813,1.0,9/31,14.96%,KAT6B;ACAT1;SAT2;PAFAH1B2;NAT14;PAFAH2;CREBBP;KAT8;NAA10
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3164998724567243,-0.756009896478312,0.7597087378640777,0.927029817541889,1.0,7/10,38.29%,KAT2B;CDKN2C;CDKN1B;CDKN2D;HEXIM2;CDKN2B;INCA1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3085375818499009,-0.7559634318543914,0.7844036697247706,0.9229466161727161,1.0,2/11,7.55%,KSR1;MAP2K2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.32148821415938456,0.7558037427937199,0.7381342062193126,0.9873541887982862,1.0,1/17,1.39%,AK5
prerank,calcium-activated potassium channel activity (GO:0015269),-0.31250280289613663,-0.7548540230224775,0.7777777777777778,0.9204052603664871,1.0,7/11,37.42%,KCNMA1;KCNN2;KCNN3;PKD2L1;KCNN4;KCNN1;KCNMB2
prerank,DNA polymerase binding (GO:0070182),0.3168003598986657,0.7544064011115287,0.7578253706754531,0.9867166109028981,1.0,4/18,14.12%,HMGB1;LONP1;CDK2AP1;POLG2
prerank,lipase activator activity (GO:0060229),0.3565286717140171,0.7481199491923999,0.7668393782383419,0.9935831001153791,1.0,3/10,18.55%,SRC;BTK;PDPK1
prerank,GTPase binding (GO:0051020),0.2238705394657572,0.7478531629871107,0.9036144578313253,0.9911649432411644,1.0,44/195,18.93%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;GCC1;AKAP13;LZTR1;RAPGEF4;RAB3GAP2;RAPGEF6;OCRL;ABCA1;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;DMXL2;RANBP2;EXOC5;EVI5;TRIP11;RRAGB;AIMP1;PDE6D;RAB34;UNC13B;CHM;AP3M1;TBC1D20;RTKN;BNIP3;XPO5;ARHGDIB;RALBP1;ALS2;SPTBN1;LCP1;SIKE1;EHD1;DENND10;ANKFY1;RAF1
prerank,glutamate receptor activity (GO:0008066),-0.2594177350473942,-0.747666289073548,0.8154269972451791,0.9254971453956538,1.0,3/19,7.84%,GRM3;GRIA2;GRIK2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2949242865248921,0.7449545488326849,0.7637195121951219,0.9928450756271101,1.0,4/24,8.79%,SESTD1;LANCL2;CERT1;OBSCN
prerank,ubiquitin-specific protease binding (GO:1990381),0.30585218054566216,0.742025331401343,0.7832512315270936,0.994377176630533,1.0,8/19,22.70%,SELENOS;AMFR;PTEN;LCOR;SUMO1;PRKN;DERL1;RHBDD2
prerank,chloride channel activity (GO:0005254),0.25246732746640627,0.7416932478110484,0.8236092265943012,0.9920674477973802,1.0,9/59,12.26%,SLC26A9;ANO6;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3153359849477998,-0.739980710755925,0.7884615384615384,0.9268898210023993,1.0,7/10,43.59%,DUSP10;DUSP7;DUSP1;DUSP4;DUSP5;DUSP16;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3153359849477998,-0.739980710755925,0.7884615384615384,0.9268898210023993,1.0,7/10,43.59%,DUSP10;DUSP7;DUSP1;DUSP4;DUSP5;DUSP16;DUSP2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2517630518360186,-0.7384889922719337,0.8623595505617978,0.9247467045285056,1.0,7/22,18.05%,RBMS3;CPEB2;ZC3H12A;CPSF1;ZFP36;DHX36;CPEB1
prerank,tRNA methyltransferase activity (GO:0008175),0.31471704374194676,0.7324593487291564,0.7829716193656093,1.0,1.0,6/16,18.39%,TARBP1;FTSJ1;TRMT5;THUMPD3;METTL2A;METTL2B
prerank,neuropeptide binding (GO:0042923),0.31435696030939986,0.7316393120130598,0.7786885245901639,1.0,1.0,1/18,2.40%,SSTR1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.21906936256784917,-0.7314079434593357,0.8806451612903226,0.9294956624942717,1.0,13/35,25.19%,TRMT13;QRSL1;TRIT1;TRMT9B;TRDMT1;PUS10;DUS3L;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,P-type ion transporter activity (GO:0015662),-0.290001845300528,-0.7292815063613245,0.8132118451025057,0.9279090491440644,1.0,3/12,13.55%,ATP7A;ATP2C1;ATP2B3
prerank,symporter activity (GO:0015293),-0.3049718759169694,-0.7262459569338064,0.7813953488372093,0.9278244730014243,1.0,2/10,13.12%,SLC5A6;MFSD2A
prerank,3'-5' exonuclease activity (GO:0008408),0.25826703472449863,0.7231040255239248,0.8606224627875507,1.0,1.0,14/45,21.48%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;REXO4;REV3L;CNOT8;PNLDC1;TOE1;MRE11;RAD9A;EXOSC7
prerank,Hsp70 protein binding (GO:0030544),-0.2223999190051613,-0.7227971559721408,0.9057750759878419,0.9278447840291976,1.0,18/31,39.88%,DNAJB2;DNAJA1;GPR37;RPS3;HDAC8;NOD2;DNAJC2;TSC1;DNAJB1;MVD;PPID;FICD;PACRG;SNCA;RNF207;PPEF2;DNAJB14;CYP2E1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2562351997957424,-0.7224642795708391,0.8341968911917098,0.9241926072322607,1.0,12/19,37.80%,MCM6;POLQ;HELQ;RFC2;RAD51;RFC4;MCM7;MCM5;MCM2;RFC5;CHTF18;PIF1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.27686578686879887,0.7198204257843486,0.8169642857142857,1.0,1.0,9/28,22.54%,GRID1;GABRG2;GABRG1;GRIK1;GRIK5;CHRNA7;GABRA3;GRIK3;GRID2
prerank,sterol transfer activity (GO:0120015),0.3066075130931897,0.7197899444872579,0.8056426332288401,1.0,1.0,4/17,16.51%,GRAMD1B;ABCA1;STARD5;OSBPL2
prerank,microtubule minus-end binding (GO:0051011),-0.2740335548483512,-0.7181884581290078,0.8197115384615384,0.9250731840305882,1.0,3/13,10.51%,TUBGCP4;CAMSAP1;MACF1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.32888356638597377,0.7173843550662103,0.8047138047138047,1.0,1.0,5/12,29.12%,BACE2;BACE1;HM13;SPPL3;CTSE
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.30445156024361153,0.7170334578648088,0.8118195956454122,1.0,1.0,15/15,69.58%,PLA2G4A;PLA2G4C;PLA2G4E;PLA2G1B;PLA2G4D;PLA2G2E;PLA2G2F;PLA2G12A;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4F
prerank,5'-3' exonuclease activity (GO:0008409),0.31600917773033693,0.7158810347089639,0.8159722222222222,1.0,1.0,3/14,19.02%,DXO;EXOG;MRE11
prerank,ferrous iron binding (GO:0008198),-0.24111444437370877,-0.7150451036688892,0.847953216374269,0.924688955810435,1.0,5/21,14.08%,EGLN1;FTH1;FTL;FECH;FXN
prerank,microtubule plus-end binding (GO:0051010),-0.2435531918631784,-0.7146052486625478,0.8825136612021858,0.9213246335552339,1.0,2/20,3.37%,CLIP1;DST
prerank,MHC class I protein binding (GO:0042288),0.32279498824996045,0.7134405373164204,0.8016806722689076,1.0,1.0,4/13,21.89%,TAPBP;ABCB9;ATP5F1A;DERL1
prerank,nucleotidase activity (GO:0008252),-0.26564192449551693,-0.7122625566410008,0.8526315789473684,0.9198657048626976,1.0,5/15,18.92%,BPNT2;NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,nuclear localization sequence binding (GO:0008139),0.2947521803089937,0.708324176714735,0.8174603174603174,1.0,1.0,3/18,13.02%,KPNA7;KPNA2;NUP153
prerank,estrogen receptor binding (GO:0030331),0.2636424711681877,0.7075913497377614,0.837410071942446,1.0,1.0,9/32,19.99%,TAF10;NRIP1;ISL1;DCAF13;STRN;LCOR;CCDC62;CNOT1;TACC1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2475558597270595,0.7054730539836829,0.8619756427604871,1.0,1.0,10/49,17.06%,DUSP12;ACP6;PTPN22;ATP1A2;PTPRJ;ARMT1;DUSP8;PTPRO;GDPD3;PPP1CA
prerank,O-methyltransferase activity (GO:0008171),-0.2986459676739146,-0.7029203629091795,0.819672131147541,0.9257708927027677,1.0,2/10,11.76%,COMT;COQ3
prerank,cysteine-type peptidase activity (GO:0008234),0.23053976663614142,0.6986752371349928,0.8857509627727856,1.0,1.0,12/73,14.70%,USP50;TINAGL1;USP8;USP48;BLMH;USP47;USP13;OTUD7B;USP15;CAPN2;ATG4C;USP35
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3050987540691609,0.6966573925955475,0.8137254901960784,1.0,1.0,4/15,20.36%,PI4K2B;PIK3C3;PI4K2A;PIK3C2B
prerank,acylglycerol lipase activity (GO:0047372),0.319526925960942,0.6946801428124912,0.8303249097472925,1.0,1.0,3/11,19.50%,ABHD12;LIPE;FAAH
prerank,hexosyltransferase activity (GO:0016758),0.2182011105063731,0.6897628035648175,0.9178571428571428,1.0,1.0,12/101,10.86%,OGT;B3GALT1;A4GALT;GCNT4;B4GAT1;B3GLCT;PIGB;GCNT2;DPY19L4;POFUT1;ALG9;HEXA
prerank,rRNA binding (GO:0019843),-0.1998159542750431,-0.6865083435547319,0.96,0.9380607727235001,1.0,17/42,27.69%,RPLP0;MRPS6;RPS3;RPL23;NGRN;MRPL18;MRPS27;MRPS11;PPAN;RPL5;MTERF4;RPS9;RPS14;ERAL1;FASTKD5;RPF2;RPL11
prerank,protease binding (GO:0002020),0.2162018526303512,0.685666503332638,0.9170560747663551,1.0,1.0,15/99,13.02%,FAP;SLC2A13;FN1;TNFAIP3;SELENOS;COL3A1;NLRC4;DPP4;AMFR;ATP9A;GSK3B;DVL3;COL1A1;PTEN;ADAMTSL4
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23396259832622332,-0.6856052359105329,0.9073569482288828,0.9350537847001018,1.0,6/20,21.94%,RPS3;ZRANB3;ERCC4;DCLRE1C;APLF;ERCC5
prerank,guanyl ribonucleotide binding (GO:0032561),0.20304182194329107,0.6822900957210023,0.958963282937365,1.0,1.0,22/196,9.35%,RAP1A;RAB8B;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;ARL11;PIP4K2B;CNGB1;ARHGEF5;NRAS;KRAS;CNGA4;RHOJ;TUBG1;GNL2;ATL2;ARF6;MIEF1;ARL4A
prerank,ATPase regulator activity (GO:0060590),0.24575372243568028,0.6805311337130363,0.8873435326842837,1.0,1.0,10/38,19.36%,HSPH1;SIL1;BAG3;ATP1B3;AHSA1;BAG2;DNAJC24;DNAJB4;DNAJC19;GRPEL2
prerank,ligand-gated calcium channel activity (GO:0099604),0.2817890246967046,0.680391199260998,0.8612804878048781,1.0,1.0,1/19,1.41%,ITPR3
prerank,SUMO binding (GO:0032183),0.3070161767381591,0.6783717343957486,0.8446601941747572,1.0,1.0,1/13,2.63%,TDG
prerank,deoxyribonuclease activity (GO:0004536),-0.25979184397229155,-0.6731977583472053,0.8708133971291866,0.9424176211225662,1.0,5/14,21.94%,RPS3;ZRANB3;ERCC4;APLF;ERCC5
prerank,nuclease activity (GO:0004518),0.23798026598357622,0.6716419190024299,0.9023066485753053,1.0,1.0,18/52,26.47%,NTHL1;N4BP1;DIS3L2;DFFB;PLSCR1;EXOG;REXO1;REXO4;RNASE3;MRE11;NME1;N4BP2;RNASE1;RNASEH1;DNASE1L1;OGG1;AEN;ANG
prerank,endonuclease activity (GO:0004519),0.23207854270815884,0.6697128161259757,0.921595598349381,1.0,1.0,8/49,16.32%,PIWIL2;NTHL1;AGO1;EXOG;ERN1;DICER1;REXO4;TSNAX
prerank,retinoid X receptor binding (GO:0046965),0.3054052448505935,0.6693817273014954,0.8453237410071942,1.0,1.0,4/11,19.99%,NRIP1;RARG;PPARG;TACC1
prerank,nuclear receptor binding (GO:0016922),0.20741299589443074,0.6685647917036665,0.9549132947976878,1.0,1.0,28/111,21.69%,PPARGC1A;TAF10;NRIP1;NCOR1;ISL1;DCAF13;MED13;TMF1;STRN;NCOR2;JMJD1C;NCOA3;NCOA2;GTF2H1;BAZ2A;BRD8;LCOR;CCDC62;MED12;CNOT1;TACC2;TACC1;STAT5B;RNF14;MED16;DAXX;ARID1A;TCF7L2
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.16147019648233815,-0.6674037533428399,0.9894179894179894,0.9434025636337856,1.0,13/85,15.89%,ENPP2;NDST3;LYPLA1;NOTUM;ASPG;ABHD5;ABHD3;PNPLA6;ABHD2;LYPLAL1;LIPA;PGLS;CA2
prerank,glucose transmembrane transporter activity (GO:0005355),0.2828256427582544,0.6658215519603501,0.8593508500772797,1.0,1.0,3/17,12.77%,SLC2A2;SLC5A3;SLC5A11
prerank,GTP binding (GO:0005525),0.2009354572503732,0.6654464974174017,0.9701327433628318,1.0,1.0,17/172,7.65%,RAP1A;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;ARL11;PIP4K2B;ARHGEF5;NRAS;KRAS;RHOJ;TUBG1;GNL2;ATL2;ARF6
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.23531905186513863,0.6633647483006055,0.925035360678925,1.0,1.0,11/40,18.81%,TARBP1;SUV39H1;LRTOMT;GAMT;METTL9;ARMT1;LCMT1;THUMPD3;METTL2A;METTL2B;ICMT
prerank,exonuclease activity (GO:0004527),0.23257766041659392,0.6622331016306169,0.8980132450331125,1.0,1.0,10/46,14.70%,EXOSC5;DXO;REXO2;EXOSC10;CNOT7;EXOG;APEX2;REXO1;REXO4;REV3L
prerank,hexose transmembrane transporter activity (GO:0015149),0.303822438921269,0.661252096974483,0.8571428571428571,1.0,1.0,3/12,19.77%,SLC2A2;SLC5A3;MFSD4A
prerank,protein kinase regulator activity (GO:0019887),0.20411810174029177,0.6549735959432371,0.9486873508353222,1.0,1.0,12/95,12.13%,PARVA;CCND3;PRKAG1;SPRY4;CCNG1;GMFB;PRKAR2A;CCNJ;MAPK8IP1;APC;HEXIM1;FAF1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.24272034122645902,0.6546189494060712,0.9014285714285715,1.0,1.0,10/34,22.64%,SUV39H1;MEN1;ATPSCKMT;SETD2;CAMKMT;ETFBKMT;KMT5A;SETDB1;VCPKMT;EEF2KMT
prerank,U6 snRNA binding (GO:0017070),0.28709898495983954,0.6540292432373396,0.8501683501683501,1.0,1.0,2/14,7.90%,TUT1;RBM22
prerank,glucuronosyltransferase activity (GO:0015020),0.2734458120505958,0.6521670551078853,0.8678343949044586,1.0,1.0,5/19,25.41%,B4GAT1;EXT1;EXT2;B3GAT2;CHPF
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.25246028531169273,0.6511801210753748,0.8970149253731343,1.0,1.0,6/29,14.92%,SLC25A12;SLC26A9;SLC1A6;SLC25A13;SLC25A22;SLC46A1
prerank,transmitter-gated ion channel activity (GO:0022824),0.2486663619568272,0.6500804956527592,0.900593471810089,1.0,1.0,11/29,23.75%,GRID1;GABRG2;GABRG1;GABRB3;GLRA3;GRIK1;GRIK5;GABRA3;GRIK3;GRID2;GRIA4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.2579786315753817,0.6500649179578887,0.8822605965463108,1.0,1.0,3/22,13.05%,DUSP12;MTMR3;DUSP8
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3061513986043688,0.6482452124243118,0.8467023172905526,1.0,1.0,1/10,5.55%,SLC6A13
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.27754596897179096,0.6450342968939832,0.8770226537216829,1.0,1.0,3/15,20.71%,KMT2A;KMT2D;ASH2L
prerank,NAD+ binding (GO:0070403),0.2912511766643664,0.6446320086547621,0.8758278145695364,1.0,1.0,5/12,22.93%,SIRT3;HPGD;GLUD1;SIRT2;UXS1
prerank,damaged DNA binding (GO:0003684),0.23330666816928733,0.6441268535189455,0.9098474341192788,1.0,1.0,8/44,17.29%,TDG;NTHL1;NBN;HMGB1;ERCC1;CREBBP;DDB2;CUL4B
prerank,phosphatidylglycerol binding (GO:1901611),0.2857858960833425,0.6372182242770751,0.885483870967742,1.0,1.0,3/13,13.88%,PITPNC1;MME;GSDMD
prerank,double-stranded RNA binding (GO:0003725),0.21376261174085254,0.6357911670659072,0.9479034307496823,1.0,1.0,24/70,24.99%,ZNF346;TLR7;ZFR;ILF2;SIDT2;AGO1;STAU2;ILF3;DGCR8;STRBP;FXR1;DICER1;PRKRA;OAS2;DHX9;ADARB1;ELAVL1;IFIH1;ACTN1;DHX58;TUBA1B;PRKRIP1;DHX30;FMR1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.28502673539323764,0.6297919461615196,0.8690476190476191,1.0,1.0,3/12,12.26%,GABRG2;GABRG1;GABRB3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.2481266733825797,-0.6256250708957238,0.9197080291970803,0.9691904509680921,1.0,1/12,1.28%,ENTPD1
prerank,pentosyltransferase activity (GO:0016763),0.22951040620979862,0.6255824020442591,0.9177126917712691,1.0,1.0,6/36,14.68%,UPP2;SIRT3;PPAT;PARP11;PARP6;PARP8
prerank,retinoic acid receptor binding (GO:0042974),0.2610585214759267,0.6249672125559597,0.8993288590604027,1.0,1.0,5/17,19.99%,NRIP1;RARG;PPARG;CNOT1;TACC1
prerank,5'-nucleotidase activity (GO:0008253),-0.23999617778712914,-0.6234190368374458,0.9371859296482412,0.9666228629481403,1.0,4/13,18.92%,NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2347963764420359,0.6183897576851107,0.9292035398230089,1.0,1.0,10/28,25.77%,POP4;POP7;DBR1;RPP14;DICER1;RPP21;RPP30;RNASEH1;PRORP;AGO2
prerank,ligand-gated channel activity (GO:0022834),0.23579539140721786,0.6176681143050875,0.9104704097116844,1.0,1.0,4/29,9.86%,GRIA3;CNGB1;GRID1;GRIA1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.28849123611792005,0.6175834361703342,0.8823529411764706,1.0,1.0,4/11,19.07%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,muscle alpha-actinin binding (GO:0051371),0.2690580584214753,0.6171010282575954,0.9013157894736842,1.0,1.0,1/15,2.25%,PDLIM4
prerank,ligand-gated ion channel activity (GO:0015276),0.23389480015101632,0.6170836896125272,0.9052631578947369,0.9994905042145232,1.0,4/30,9.86%,GRIA3;CNGB1;GRID1;GRIA1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2770194466093351,0.6048391976232729,0.8843537414965986,1.0,1.0,6/11,28.26%,NAA10;NAA40;NAA60;NAA30;NAA20;NAA80
prerank,translation initiation factor activity (GO:0003743),0.2235051203374293,0.6019559566491391,0.9465541490857946,1.0,1.0,6/36,14.90%,EIF2B3;EIF5B;EIF4E;EIF1;EIF2B4;COPS5
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.2741189930335057,0.5998800077080096,0.9066901408450704,1.0,1.0,4/12,19.07%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,leucine zipper domain binding (GO:0043522),-0.24991945103931018,-0.5970241926868797,0.9218009478672986,0.9769252047384275,1.0,3/10,19.54%,PAWR;ATF4;DAPK3
prerank,aspartic-type peptidase activity (GO:0070001),0.2836636316048632,0.5943223755512332,0.9198606271777003,1.0,1.0,2/10,16.37%,BACE2;BACE1
prerank,histone deacetylase binding (GO:0042826),0.18884378432534907,0.59223343522081,0.9829059829059829,1.0,1.0,24/88,22.92%,SPI1;HDAC4;DACT1;KPNA2;HIC1;NCOR1;HDAC2;NCOR2;HDAC6;SFPQ;CAMTA2;LCOR;YWHAE;GMNN;MTA3;HDAC3;RBBP4;PRKN;NUDT21;MAPK8;RAD9A;BRMS1L;YWHAB;SIRT2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23619914106130668,0.5814759087011165,0.9523809523809523,1.0,1.0,8/21,24.44%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;PRIMPOL;REV1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.1872458926921878,-0.577069570527597,0.968299711815562,0.9820447383973412,1.0,9/25,29.27%,ART3;ZC3HAV1;PARP2;PARP10;PARP1;TNKS2;PARP3;PARP16;SIRT6
prerank,Hsp90 protein binding (GO:0051879),0.21397097997443068,0.5762197084696091,0.967741935483871,1.0,1.0,6/33,16.12%,SLC12A2;NPAS2;HDAC6;AHSA1;ERN1;CHORDC1
prerank,DNA polymerase activity (GO:0034061),0.23156409112287996,0.5736030575624755,0.9518072289156626,1.0,1.0,8/22,24.44%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;PRIMPOL;REV1
prerank,ligand-gated anion channel activity (GO:0099095),0.23975144435454698,0.5699335751141928,0.9547738693467337,1.0,1.0,8/17,27.52%,GABRG2;GABRG1;GABRB3;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,histone methyltransferase binding (GO:1990226),-0.23169496182392063,-0.5696247146853234,0.9483568075117371,0.9809371249840021,1.0,1/11,4.33%,LCORL
prerank,Toll-like receptor binding (GO:0035325),0.25874081978532437,0.566475253223838,0.9180035650623886,1.0,1.0,11/11,74.14%,S100A9;TOLLIP;TIRAP;S100A8;TLR2;TLR1;DAB2IP;TLR6;CD36;UNC93B1;MYD88
prerank,snRNA binding (GO:0017069),0.20471689660037728,0.5630342953788229,0.979050279329609,1.0,1.0,6/42,13.66%,RNPC3;TUT1;RBM22;SNU13;HEXIM1;SNRPA1
prerank,ATP hydrolysis activity (GO:0140603),0.20025084784599348,0.5599218278430139,0.9715504978662873,1.0,1.0,3/41,4.42%,KIF20B;CHD3;VWA8
prerank,CARD domain binding (GO:0050700),0.24567550215395056,0.5564970724056377,0.9483870967741935,1.0,1.0,2/14,8.84%,CARD10;IRGM
prerank,disordered domain specific binding (GO:0097718),0.21792217259166455,0.5558005559442307,0.9608482871125612,1.0,1.0,3/23,12.16%,FN1;DFFB;NCOA3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.25635553323708504,0.5556173278293943,0.9331046312178388,1.0,1.0,11/11,74.38%,CHRNA7;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNA9;CHRNB1;CHRNB2;CHRNA4
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.25915665518394554,0.5541528940664205,0.9444444444444444,0.9996361635321918,1.0,2/10,11.18%,GABRG2;GABRG1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.20363056863305873,-0.5535423348463726,0.9405684754521964,0.9829741820683967,1.0,8/15,39.32%,P2RX7;P2RX4;GPR34;P2RY12;P2RY1;PTAFR;P2RX5;P2RX6
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.24516421461812898,0.5523374338878493,0.9554794520547946,0.9979933008206883,1.0,7/13,27.52%,GABRG2;GABRG1;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,cardiolipin binding (GO:1901612),0.24773679386681685,0.5262357091346096,0.9595278246205734,1.0,1.0,4/10,23.47%,MME;GSDMD;STOML2;UQCC3
prerank,neuropeptide hormone activity (GO:0005184),0.2072236180904523,0.5159012422735577,0.963302752293578,1.0,1.0,22/22,79.31%,HCRT;AGRP;ADCYAP1;NPFF;PPY;CCK;NPY;OXT;CORT;QRFP;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;GRP;SPX;PENK
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.218222798168591,0.5146682476063814,0.9666136724960255,1.0,1.0,8/17,25.96%,DECR2;DHCR24;DECR1;BLVRA;PECR;MECR;PTGR1;PTGR2
prerank,N-methyltransferase activity (GO:0008170),0.2096846903465232,0.5122155576273858,0.9641693811074918,1.0,1.0,6/20,22.37%,TFB2M;METTL5;TRMT1L;TRMO;TFB1M;TRMT1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.19231378577591984,0.5094948293411835,0.9882525697503671,1.0,1.0,1/32,1.84%,KCNA5
prerank,signal sequence binding (GO:0005048),0.1843312100478276,0.5058308105349464,0.9886524822695035,1.0,1.0,2/35,5.83%,KPNA7;KPNA2
prerank,DNA replication origin binding (GO:0003688),0.2025191809424505,0.5006385203621713,0.975609756097561,1.0,1.0,8/23,24.80%,ORC5;ORC3;CDC6;ORC1;DHX9;DDX11;MCM4;ORC4
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.19678531129314114,0.5004658295879717,0.9881305637982196,0.9981612913667676,1.0,2/26,7.11%,B3GALT1;EXTL2
prerank,histone methyltransferase activity (GO:0042054),-0.14651945463468583,-0.48563415566670376,0.9967637540453075,0.9954627058132577,1.0,16/32,40.95%,SMYD2;PRMT7;SUZ12;EED;FBL;EHMT2;SMYD3;TTLL12;KMT2E;NTMT1;EHMT1;SETD7;N6AMT1;CARM1;PRMT1;EZH2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.17833167103078928,-0.47805561538991936,0.9872448979591837,0.9927374178950374,1.0,8/15,48.69%,CMKLR1;CCR2;CCR9;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.1851247452000719,0.47795929000763465,0.9899135446685879,1.0,1.0,2/30,9.42%,TNFAIP8;RPS6KA3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.20764572637175818,0.4680920840331319,0.981418918918919,1.0,1.0,2/12,15.65%,DHRS4;AIFM2
prerank,telomeric DNA binding (GO:0042162),0.17857730076596823,0.46695925532577304,0.9941002949852508,0.9988896346368928,1.0,11/32,28.07%,STN1;UPF2;SMG7;TERF2;XRCC6;HNRNPD;SMG6;RAD50;SMG5;RPA1;TERF2IP
prerank,peptide N-acetyltransferase activity (GO:0034212),0.21734228936871788,0.46623275288997734,0.987719298245614,0.9967350851746795,1.0,5/10,28.26%,NAA10;NAA60;NAA30;NAA20;NAA80
prerank,translation elongation factor activity (GO:0003746),0.2013371674202525,0.4649313870137624,0.9775086505190311,0.9946640572238943,1.0,5/14,22.51%,EEFSEC;GTPBP1;GFM1;TSFM;GTPBP2
prerank,lysine N-methyltransferase activity (GO:0016278),0.17880559163193235,0.4322586183244724,0.996875,0.9970104142450629,1.0,6/20,22.64%,ATPSCKMT;SETD2;ETFBKMT;KMT5A;VCPKMT;EEF2KMT
prerank,phospholipase A2 activity (GO:0004623),0.15771926080292498,0.4040916831737154,0.9985074626865672,0.9973499929865449,1.0,5/26,25.95%,PLAAT5;PNPLA8;PRDX6;PLA2G4A;PLA2G4C
